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Polyelectrolytes are charge carrying polymers, when two oppositely charged 
polyelectrolytes are combined in a solution favouring charge expression, a 
polyelectrolyte complex can result. These complexes have been shown to be useful 
in the field of drug delivery in general. Amphiphilic polyelectrolytes contain both 
hydrophilic and hydrophobic groups as part of their structure; these amphiphilic 
polymers have shown interesting results in the field of protein and peptide delivery.  
Peptides and proteins are natural polyelectrolytes, and have been used in 
combination with other charged polymers in the delivery of peptide drugs. The oral 
route of delivery for peptides and proteins has many barriers, but is of great 
interest, due to its potential to improve patients’ adherence to medications. 
In this study poly (allyl amine) and sodium alginate were used to produce a 
polyelectrolyte complex with the peptide insulin, with a view to investigating one 
of a number of barriers preventing the peptides oral delivery, namely its enzymatic 
cleavage by α-chymotrypsin. 
Poly (allyl amine) was prepared from poly (allyl amine) hydrochloride, amphiphilic 
derivatives were prepared using palmitic acid-N-hydroxy succinamide and resulted 
in 3.7% and 5.1% palmitoyl grafted poly (allyl amine) based on elemental analysis. 
Furthermore samples were quaternised using methyl iodide and resulted in 
samples with degrees of quaternisation of 18% and 35% based on elemental 
analysis. 
alginate/poly (allyl amine) complexes were analysed at a number of mass ratios 
and using a number of techniques including dynamic light scattering, differential 
scanning calorimetry with hot-stage microscopy, zeta potential, and infra-red 
analysis. 
Results showed that alginate and the different derivatives of poly (allyl amine) 
resulted in nano-sized aggregates with estimated hydrodynamic diameters ranging 
from 130-400nm. Thermal analysis showed that complexation appeared to have 
resulted in changes in the thermal decomposition temperatures of polymers. 
Variations in the vibrational frequencies of infra-red results for analysed samples 
were used as evidence of polyelectrolyte interactions. Zeta potential of select 
samples resulted in values >50mV, indicating good colloidal stability of nano-
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aggregates. Transmission electron microscopy showed the formation of distinct 
spherical particles, and agglomerations of spherical and needle shaped particles. 
Polyelectrolyte complexes of poly (allyl amine), sodium alginate, and insulin were 
prepared at a different pH, but were investigated using similar methods as 
complexes of poly (allyl amine) and sodium alginate without insulin. Dynamic light 
scattering results showed the formation of complexes with estimated 
hydrodynamic diameters of 150-200nm. Thermal analysis showed changes in the 
thermal decomposition temperatures of complexes compared to individual 
polyelectrolytes. Infra-red analysis showed small variations in vibrational 
frequencies which were seen as signs of electrostatic interaction. Reverse phase 
high performance liquid chromatography was used in enzymatic studies to 
ascertain whether prepared polyelectrolyte complexes were capable of protecting 
insulin from the enzymatic activity of α-chymotrypsin, results showed that 
complexes appeared to increase the susceptibility of insulin to enzymatic cleavage, 
with results after 2 hours incubation with α-chymotrypsin showing <5% remaining 
insulin for complexes, whereas insulin control show approximately 35% remaining 
peptide after 2 hours in the presence of the enzyme. 
The polyelectrolytes used appeared to result in stable complexes maintained by a 
combination of electrostatic and hydrophobic interactions, however these 
interaction also appeared to lead to increased degradation of insulin by α-
chymotrypsin. 












1.1 Insulin and barriers of oral delivery 
Insulin is a 51 amino acid endogenous protein that controls blood sugar (figure 
1.1). Therapeutically it can be used in the management of type-1 diabetes, as well 
as advanced cases of type-2 diabetes. Lifelong treatment with insulin is often 
required, involving multiple daily subcutaneous injections in order to maintain 
control over glucose levels in the blood. Otherwise, uncontrolled hyperglycaemia 
may eventually lead to a number of debilitating, and possibly fatal endpoints, 
including: neuropathy, retinopathy, and nephropathy as well as the more acute 
complications, hyperosmolar hyperglycaemic state in type-2 diabetes, and diabetic 
ketoacidosis in type-1 diabetes. An oral delivery agent for insulin has been a target 
of research since the isolation and purification of insulin in 1922, with a number of 
different delivery systems being investigated by companies around the world (1). 
In general, most delivery systems to date have met with limited success. 
The barriers towards insulin and peptide oral delivery have been thoroughly 
covered in the literature; therefore this section will be concise. 
One of the first barriers encountered by the insulin molecule would be the acidic 
environment of the stomach. Brange et al. suggested that the rapid deterioration 
of insulin in acidic conditions was due to the deamidation of asparagine, the 21st 
amino acid of the insulin A chain (2). The stomach also contains the enzyme 
pepsin, the team of Lee and Ryle showed the probable cleavage sites of the insulin 
B chain by pepsin to be as follows: 
Phenylalanine1/Valine, glutamine4/histidine, glutamic acid13/alanine, 
alanine14/leucine, leucine15/tyrosine, tyrocine16/leucine, glycine23/phenyl alanine, 
phenyl alanine24/phenyl alanine, phenyl alanine25/tyrosine (3). 
The intestine also contains a variety of proteases (which are the enzymes 
responsible for the digestion of proteins and peptides in food) whose purpose is to 
further digest material coming from the stomach. Examples of proteases include 
trypsin, α-chymotrypsin and the carboxypeptidases. Zhang et al. show the 
enzymatic cleavage sites of insulin by trypsin and chymotrypsin as follows: 
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Trypsin was shown to cleave insulin at glutamic acid21/arginine, and 
proline27/lysine on the B chain. 
Chymotrypsin was shown to cleave insulin at leucine13/tyrosine, and 
asparagine18/tyrosine on the A chain. While on the B chain it was found to cleave 
at leucine15/tyrosine, phenyl alanine24/phenyl alanine, and phenyl 
alanine25/tyrosine (4). The cleavage sites of the proteases can be seen in Figure 
1.1. 
 
Figure 1.1 Primary amino acid structure of insulin. Arrows indicate the cleavage 
sites of proteases. Hollow arrow: pepsin, solid arrow: trypsin, dashed arrow: α-
chymotrypsin. 
The small intestine is responsible for the absorption of digested nutrients, while 
acting as a barrier against the infiltration of harmful microorganisms. This is also 
the case for large molecules such as undigested protein. The natural process would 
be for protein to be digested, with consequent di/tri peptides absorbed by a group 
of transport proteins termed the proton-dependant oligopeptide transporters (5). 
Other barriers to protein delivery in general include the mucous membrane lining 
the intestinal epithelia, cellular efflux pumps, and cellular enzymes. Together these 
barriers limit the intestinal absorption of complete proteins to less than 1% (6). 
The combination of these barriers shows the complexity of the problem facing oral 
delivery of insulin and other peptides.   
1.2 Alternative protein and peptide delivery 
Invasive injections are currently the most effective way to deliver protein and 
peptide drugs, and with the rapid growth of protein therapeutics, it is essential 
that the science of protein and peptide delivery keeps pace with developments. 
The delivery of peptides and protein by any route other than the parenteral is 
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complicated by the relative fragility of proteins, which require specific conditions 
of temperature, pH, and the surrounding environment in order to be fully effective. 
The difficulties of protein delivery and the steps taken to overcome them have 
been widely covered in the literature (7). Therefore the focus of this section will 




Ocular delivery of any therapeutic agent is challenging due to the natural 
physiology of the eye which includes barriers such as low corneal permeability and 
nasolacrimal drainage. Peptide delivery by the ocular route would be further 
hindered by the large size of peptides, their susceptibility to metabolism, and 
hydrophilicity leading to poor membrane permeability (8). However Pillion et al. 
were able to reduce the blood glucose of streptozotocin diabetic rats using eye 
drop solutions of insulin and saponin, a plant based surfactant (9). 
Yamamoto et al. used a number of absorption enhancers including 
polyoxyethylene-9-lauryl ether, sodium deoxycholate, sodium glyococholate, and 
sodium taurocholate in a study of the ocular delivery of insulin. The group were 
able to achieve systemic bioavailability values of 3-8% of administered insulin 
dose. Furthermore the groups showed that 80% of the bioavailability was in fact 
due to absorption through the nasal mucosa (following nasolacrimal drainage) 
rather than conjunctival epithelia (10). 
 
Nasal 
Nasal delivery of peptides has usually involved the use of permeability enhancers 
and/or mucoadhesive agents. 
Wang et al. used gelatin and aminated gelatin in the place of surfactants and bile 
salts, as absorption enhancers in investigations towards the nasal delivery of 
insulin. The group prepared microspheres of gelatin and insulin, they then analysed 
whether dry microspheres or microsphere suspensions were able to improve 
insulin bioavailability. The suspensions were not found to result in any significant 
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reduction in blood glucose of male Wistar rats. However, the powder forms of 
gelatin/insulin and aminated gelatin/insulin microspheres resulted in reductions in 
plasma glucose levels of 9.3% and 13.8%, respectively (11). 
Cho et al. prepared spray dried particles of salmon calcitonin with absorption 
enhancers: chitosan, sodium taurocholate, and beta-cyclodextrin. The group 
performed an in vivo test using Sprague-Dawley rats by administering their powder 
to the nasal cavity. Their results showed a four-fold increase in serum calcitonin 
compared to an unprocessed control (12). 
The nasal pathway can also be used in the delivery of peptides to provide a local 
effect in the brain. Kamei and Takeda-Morishita used a solution of insulin and the 
cell penetrating peptide, penetratin, in an attempt to deliver insulin via the nasal 
route to the brain, with a view to investigating its effect in the treatment of 
Alzheimer’s disease. The group were able to transport insulin to the cerebral 
cortex, cerebellum, and brain stem of mice while avoiding excessive systemic 
insulin delivery (13). 
 
Transdermal 
Transdermal delivery of proteins and peptides has been investigated using a 
number of methods including liposomes, permeation enhancer, microporation, 
iontophoresis, and sonophoresis; with some more successful than others due to 
the inherent difficulty of delivering relatively large molecules across the body’s first 
line of defence (14). 
Yin et al. prepared a liposomal dry powder for the transdermal delivery of human 
epithelial growth factor, and studied the ability of the liposomes to penetrate ex 
vivo mouse skin using fluorescent microscopy. The group suggested that the 
transdermal hydration gradient forces liposomal vesicles through the stratum 
corneum towards the epidermis (15). 
Yerramsetty et al. investigated 22 chemical permeation enhancers for the 
transdermal delivery of an insulin analogue, as well as testing for toxicity. 
Solutions of permeation enhancers were added to insulin solutions and analysed 
using Franz permeation cells. The group found 8 non-toxic chemical permeation 
enhancers that had a four-fold higher permeability coefficient than control (16). 
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Bai et al. combined iontophoresis and microporation in a study investigating the 
transdermal delivery of bovine serum albumin using both in vitro and in vivo 
models. The group showed that the combination of the two techniques led to 
improved transdermal penetration of albumin (300μm) compared to microporation 
alone (150μm) based on images from confocal microscopy, while the fluorescent 
intensity of labelled albumin was 23.7 times higher in vitro and 8.2 times greater 
in vivo. Furthermore, using Franz permeation cells it was shown that the combined 
techniques led to the rate of permeation being increased 5 fold (17). 
 
Pulmonary 
The pulmonary route provides interesting possibilities for the delivery of proteins 
and peptides due to large surface area, and abundance of vasculature. However, 
just as with other routes, there are barriers towards optimal delivery, such as 
mucocilliary clearance, macrophage activity in the alveoli, and a number of 
pulmonary enzymes including elastase, collagenase, chymotrypsin, 
aminopeptidase, among others (18). 
A variety of techniques have been used in investigations towards successful 
pulmonary protein delivery. The team of Huang and Wang developed a cholesterol 
based liposomal pulmonary delivery system for insulin, whereby mice were 
exposed to aerosolised solution of nano sized liposomes. A fluorescent probe 
showed that the liposomes were well distributed in the alveoli. Furthermore, the 
results of in vivo administration of liposomes showed that the liposome 
encapsulated insulin caused a reduction in blood glucose level over at least 6 
hours. The group suggested that the liposomes encouraged a process of surfactant 
recycling, and subsequent uptake of liposomes containing insulin (19). 
Dong et al. investigated the pulmonary absorption enhancing effect of 
polyamidoamine dendrimers for model peptides insulin and calcitonin; the group 
used an in vivo study on rats, where a solution of dendrimers and peptide were 
administered directly to the lungs of anaesthetised rats. Results showed a 2.8 fold 
reduction in serum glucose and 3.1 fold increase in the bioavailability of insulin. 
Results for calcitonin showed a 2.8 fold reduction in serum calcium and 2.8 fold 
increase in the bioavailability of calcitonin (20). 
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Attempts to deliver insulin by inhalation have led to some interesting results with 
a number of candidates emerging, only to be withdrawn from the market. Including 
dry powder inhaler Exubera (Nektar Therapeutics (San Carlos, California)/Pfizer 
Inc. (New York, New York)), which was famously withdrawn from the market 1 
year after its release. Afrezza (MannKind Corporation, Valencia, California), AIR 
Insulin (Alkermes Inc. (Dublin, Ireland)/Eli Lilly and company (Indianapolis, 
Indiana)), and Technosphere insulin (TI; MannKind) were some of the other 
powder based inhaled insulin devices investigated. Of those devices mentioned 
above, the only candidate still under investigation is the next generation of devices 
from MannKind based on a combination of the technologies used for Afrezza and 
Technosphere insulin. Aerosolised liquid inhalers for insulin, such as AERx insulin 
diabetes management system (iDMS) (Aradigm corporation clinical therapeutics 
(Hayward, California)/Novo Nordisk (Bagsvaerd, Denmark)) were also 
investigated, however they suffered from a number of drawbacks including the 




The oral route of delivery is generally the most accepted route among patients. 
However proteins cannot be delivered via this route in their native state. This is 
due to the many challenges encountered by the relatively large (difficult 
absorption), and fragile (high enzymatic susceptibility) proteins and peptides. 
Some of the techniques used to improve oral protein and peptide delivery are 
similar to those used for other routes, such as liposomes, permeation enhancers, 
and protease inhibitors, among others. A small section will be exhibited here while 
more comprehensive reviews of all the different methods can be found in the 
literature (22). 
Liposomes, as mentioned above, are a well-known technique in oral peptide 
delivery. Parmentier et al. prepared liposomes containing human growth hormone 
with a number of permeation enhancers, including cetylpyridinium chloride, phenyl 
piperazine, and sodium caprate. The group used glycerylcaldityl tetraether to 
stabilise the liposomes and slow the release contents. Results showed the 
formation of nano-sized vesicles, which were able to provide a measure of 
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improvement in bioavailability. In the case of cetylpyridinium chloride, the 
bioavailability was estimated at 3.4% compared to 0.01% for protein control. It is 
important to mention that the dose of human growth hormone used was 
approximately 26 times higher than the subcutaneous dose given as standard 
(23). 
Huang et al. prepared liposomes for the oral delivery of salmon calcitonin by a 
multifunctional approach, incorporating the following permeation enhancers with 
the liposome carrier: trimethyl chitosan, which is thought to widen the paracellular 
pathway, and oligoarginine, a cell penetrating peptide whose activity is attributed 
to the induction of micropinocytosis. The two positively charged permeation 
enhancers were adsorbed onto the negatively charged liposomal surface by 
electrostatic interaction. Results of an in vivo test on Sprague-Dawley rats showed 
that the trimethyl chitosan/arginine modified liposomes resulted in a 16.6 fold 
reduction in blood calcium levels compared to non-modified calcitonin liposomes 
(24). 
The use of stimuli responsive hydrogels have shown interesting results in the field 
of protein and peptide delivery. Gao et al. prepared hydrogels for the oral delivery 
of insulin. They use a carboxymethyl cellulose/poly(acrylic acid) hydrogel hybrid 
which swells and releases its contents at intestinal pH. Using streptozotocin 
induced diabetic Wistar rats, the group were able to reduce serum glucose to 
72.4% of baseline 6 hours after intragastric administration of the insulin 60IU/kg 
hydrogel oral dose, this was calculated as a bioavailability of 6.35% compared to 
an insulin 3IU/kg subcutaneous standard (25). 
Another option in protein and peptide delivery is to make use of the polyelectrolyte 
nature of proteins and peptides and their ability to interact electrostatically with 
other materials of polyelectrolyte nature. Ibie et al. used derivatives of the 
polymer, poly(allyl amine), to prepare a polymer/insulin complex based on 
electrostatic interaction. The group investigated the cellular uptake of fluorescent 
polymer/insulin complexes by Caco-2 cells. Results of fluorescent microscopy 
showed that some of the polymer/insulin samples, notably those employing 
quaternised and thiolated polymer derivatives, appeared to have been internalised 
by the cells, the mechanism of internalisation was unclear but appeared to be 
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unaffected by calcium dependant mechanisms or the down-regulation of insulin 
receptors (26). 
The use of polymers and polyelectrolytes in combination with insulin for the oral 
delivery of the peptide will be the focus of this work. 
1.3 Polyelectrolyte complexes  
A polyelectrolyte (PE) is defined by the international union of pure and applied 
chemistry (IUPAC) as a ‘‘Polymer composed of macromolecules in which a 
substantial portion of the constitutional units contains ionic or ionizable groups, or 
both’’ (27). 
PEs can be natural, such as proteins and nucleic acids, or synthetic such as 
derivatives of polystyrene and polyacrylic acid, as well as chemically modified 
natural biopolymers such as pectin and chitosan (from the deacetylation of chitin).  
PEs can be hydrophilic, hydrophobic, or amphiphilic. They are classified 
electrochemically as polyanions and polycations, the complexation of two or more 
of which can produce polyelectrolyte complexes (PECs). 
PECs are formed by oppositely charged PEs, their association is dependent on the 
electrostatic interaction between the opposite charges, with varying influence from 
hydrogen bonding and hydrophobic interactions depending on the polymers used 
(28, 29). 
Salt concentration of the reaction medium, the degree of charge on the polymers, 
as well as the molecular weight and mixing ratio used will influence the form the 
complexes take. Changing these variables has led to aqueous PECs being 
developed either as small, homogenous, soluble complexes, colloidal PEC 
solutions, or as two phase systems of large precipitated aggregates and 
supernatant (30). 
The major factor in the formation of PECs is the release of low molecular mass ions 
(counter ions) from PEC components, which leads to increased entropy; making 
complex formation thermodynamically favourable (31). 
Structurally, PECs have been divided into stoichiometric and non-stoichiometric 
complexes (Figure 1.2). The non-stoichiometric or ‘‘sequential’’ model is when PEs 
9 
 
with large differences in molecular mass are mixed non-stoichiometrically, with 
regard to charge bearing functional groups. 
The stoichiometric model is where PEs of similar molecular masses are mixed at 
stoichiometric charge ratios and lead to either an ordered ‘‘Ladder’’ model or the 
disordered ‘‘Scrambled egg’’ model, depending on the balance between attractive 





Figure 1.2 Illustrations of assumed structural conformations of polyelectrolytes. 
(A) Ladder model (B) Scrambled egg model (C) Sequential model.  
The most commonly used PEs are generally safe to handle, non-toxic, 
biocompatible and biodegradable. Furthermore, non-toxicity is maintained even 
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after PEC formation (32-34). Such qualities, among others, have led to the 
application of PECs in a wide variety of studies, spanning the pharmaceutical, 
biomedical, and engineering fields of research (35). 
PECs have been incorporated in the synthesis of a number of different 
formulations, and a large variety of medicinal products. Tsao et al. synthesised a 
hydrogel based PEC, composed of positively charged chitosan and negatively 
charged polyglutamic acid, and investigated their antibacterial activity (36). Fukui 
et al. studied microcapsules formed of oppositely charged chitosan and alginate, 
they then proceeded to examine their ability to encapsulate albumin (a protein) 
and dextran (a polysaccharide) (37). 
Basmanav et al. synthesised PEC microspheres of polyvinyl pyridine and alginic 
acid, with a view to delivering growth factors in bone tissue engineering (38). 
Shelly et al. prepared PE nanoparticles from anionic ghatti gum and cationic 
chitosan, the antibacterial ofloxacin was then incorporated, and the group were 
able to produce a slow, sustained release of the drug while maintaining activity 
(39). 
Nanoparticle PEC formulations have been shown to have a number of advantages 
over microparticle formulations. Desai et al. showed that the uptake of PECs of 
polylactic and polyglycolic acid, by a gastrointestinal model, was dependent on 
particle size; with 0.1µm diameter particles showing a 2.5 fold better uptake than 
1µm diameter particles, as well as a 6 fold improvement when compared against 
10µm diameter particles (40). Nano-sized PEC’s may be able to improve oral 
protein delivery by a combination of enzymatic protection, intestinal adhesion, and 
cellular permeability enhancement.  
1.3.1 Hydrophilic polyelectrolytes 
1.3.1.1 Chitosan  
One of the most commonly used polycationic PEs, chitosan has been the subject 
of numerous research papers due to its natural abundance and wealth of 
favourable attributes (41, 42), some of which will be discussed in more detail.   
Chitosan is prepared by the N-deacetylation of natural chitin (Figure 1.3), a 
common biopolymer derived from the shells of shrimp and crab (43). There is also 
a technique that provides access to natural low molecular weight chitosan found 
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in certain fungi that bypasses the deacetylation step of the standard procedure 
(44). 
 
Figure 1.3 Chemical structure of (A) Chitin (B) Chitosan. 
Chitosan has been shown to be biocompatible (45), biodegradable (33), generally 
safe and lacking in toxicity. Chitin and chitosan are commonly used in a number 
of applications throughout the food industry as reviewed by Shahidi et al. (46). 
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Rampino et al. studied the biocompatibility of chitosan by using a chorioallantoic 
membrane assay (a test that used the live embryos of fertilised chicken eggs) to 
investigate any vascular changes that may arise, this was achieved by placing the 
chitosan, in solid form, in direct contact with the embryo and monitoring events 
using a microscope and camera system, the authors found no negative changes 
after 24 hours (45). 
Onishi and Macheda investigated the biodegradability of chitosan, by measuring 
the change in viscosity and molecular weight after mixing chitosan in solution with 
lysozyme, a natural enzyme found in saliva and tears. A viscometer was used and 
showed a 60% drop in viscosity after 4 hours versus a 20% drop for the control 
after 40 hours, the group attributed the change in viscosity to degradation. The 
change in molecular weight was determined by gel permeation chromatography 
after incubation of chitosan in murine plasma and urine, the results showed a ten-
fold drop in molecular weight, compared to control, indicating degradation (33). 
Chitin, chitosan, and their derivatives have been subjected to other safety studies, 
one such study investigated the effect of various chitosan solutions on the 
mucociliary transport rate in vitro and in vivo, this was done by applying chitosan 
solution to surgically removed human nasal tissue (from a procedure to correct 
deviated septa) and monitoring any changes in the mucociliary transport of 
graphite particles. The in vivo test involved placing a portion of saccharine tablet 
in direct contact with the nasal tissue of volunteers (who were to undergo the 
aforementioned procedure), the time taken to sense a sweet taste in the throat 
was interpreted as successful mucociliary transport and was measured. Results 
were compared with the time taken to sense the same taste after the 
administration of a chitosan solution nasal spray; this test was repeated for 7 days 
prior to the volunteers’ surgery. Afterwards the removed tissue was studied by 
light microscopy to assess for inflammation. Results of the in vitro test showed 
that the chitosan solutions caused a slowing of the mucuciliary transport, with 
higher molecular weight samples causing a longer duration of effect (47). 
The in vivo/in vitro test showed no negative effect on clearance or histology of 
nasal tissue. 
Mao et al. looked at the properties of depolymerised chitosan and the effect of 
molecular weight on a number of aspects, including a cytotoxicity test using a 
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mouse connective tissue fibroblast cell line MTT assay; where cultivated cells were 
placed in direct contact with various dilutions of chitosan solution and incubated 
for 24 hours. The results showed that the cytotoxicity of chitosan is concentration 
dependant, although with an half maximal inhibitory concentration (IC50) of 
4200mg/ml is relatively non-toxic, the study also found no connection between 
molecular weight and toxicity (48). These studies, a sample of many, show the 
safety profile of chitosan is robust and well documented.        
Chitosan and many of its derivatives have been and continue to be studied in the 
fields of textiles, membranes and wound dressings, flocculating agents, metal ion 
chelators, and molecular sieves in water treatment (49). 
The application of chitosan in drug delivery by forming PECs with medicinal 
compounds has been investigated in some cases. Liu et al. investigated a 
chitosan/DNA PEC produced through a simple process at a number of charge 
ratios. Using highly deacetylated chitosan (99%), they were able to produce stable 
complexes in the nanoscale range, the shape of which was assessed by atomic 
force microscopy and found to be dependent on the ratio used; with higher positive 
ratios producing more consistently regular complexes, the group also used FT-IR 
and 31P NMR to show that the incorporated DNA maintained its structure post 
complexation (50). 
Mei-chin et al. produced a nanoparticle PEC of chitosan and heparin, a 
glycosaminoglycan with a high negative charge density, its primary indication is 
as an anticoagulant in the initial treatment and prevention of deep vein 
thrombosis. The PEC was prepared by mixing heparin into a chitosan solution using 
various concentrations of each component. The authors were able to produce 
spherical nanoparticles in the range of 150nm in diameter, confirmed by 
transmission electron microscopy (TEM) and dynamic light scattering (DLS). The 
release and activity of the complexed heparin was tested both in vitro and in vivo, 
the in vitro test involved a simulated GI environment with a gradient pH media 
complete with enzymes (pepsin, pancreatin). Results were a pH dependant release 
of heparin, with very low release in the gastric simulation, as the electrostatic 
interaction at gastric pH was sufficiently robust to maintain the integrity of the 
complex. Heparin release gradually increased as the pH of the simulation was 
increased towards intestinal conditions. The in vivo test involved the oral 
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administration of the PEC nanoparticle to Sprague-Drawley rats and comparing 
bioavailability and efficacy (through measuring anti-factor Xa activity) against a 
standard heparin IV administration. Results showed an oral bioavailability of 
20.5% and plasma levels within the therapeutic range for 12 hours (51). 
Although results were promising, it should be kept in mind that the amount of 
heparin required to achieve these results was 30 times greater than that required 
in the IV administration. 
Joung-Pyo et al produced PEC nanoparticles of insulin and chitosan using different 
ratios by a simple mixing technique, resulting in particles with sizes of 150-300nm. 
The group used FT-IR and 1H-NMR to show the interaction of the two PE, as well 
as fluorescence spectrophotometry to show how the intensity peaks of insulin 
remained the same before nanoparticle formulation and after nanoparticle 
dissociation with hydrochloric acid. The release of insulin from the complex was 
analysed using a dialysis membrane and a bicinchoninic assay to assess protein 
content. Results showed insulin release over at least 120 hours for all ratios used, 
with complexes containing greater amounts of insulin showing slower release 
patterns, presumably due to greater electrostatic interaction (52). 
One of the most important properties possessed by chitosan, when discussing drug 
delivery, is mucoadhesion, which is defined as the adhesive interaction between 
the mucous membrane, and a mucoadhesive agent. Lehr et al. measured the 
mucoadhesion of a number of chitosan products of various molecular weights; this 
was achieved by measuring the force of detachment of chitosan coated cover 
glasses from pig intestinal mucosa (53).  
Abdel mouez et al. produced microspheres of chitosan and verapamil, which is an 
anti-hypertensive/anginal/arrhythmic calcium channel blocker, with a view to 
improving the drug’s poor bioavailability. These mucoadhesive microspheres, 
when administered nasally, showed 58.6% bioavailability compared to 47.8% for 
a nasal solution of verapamil alone at the same dosage (54). Indicating that 
mucoadhesion may be effective in increasing bioavailability by the nasal pathway. 
With regard to the oral pathway, studies have shown mixed results. Lueßen et al. 
were able to enhance the intestinal bioavailability of buserelin using a chitosan 
hydrochloride preparation (55), while Sakkinen et al. investigated the ability of 
chitosan/furosemide granules to increase the bioavailability of orally delivered 
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furosemide (a diuretic compound), this test was performed to assess whether the 
promising mucoadhesive results seen with in vitro chitosan tests might also be 
seen in vivo. In this case, the bioavailability was found to be no better than 
standard tablets (56). The authors followed up this study with a gamma 
scintigraphic evaluation of radio labelled chitosan granules on human volunteers, 
with results showing that adhesion occurred in 6 cases out of 10, with only 2 of 
the cases being in the small intestine (57). 
These results are less promising, although further studies using different 
formulations, perhaps micro or nano particles with greater surface area may show 
improved results. 
Mucoadhesion can be seen as something of a requirement to another of chitosan’s 
properties, namely its permeability enhancing effect. 
In oral drug delivery, the small intestine is a major site of absorption and at the 
same time a major barrier against the infiltration of foreign material, this is 
achieved through a combination of the mucous membrane, efflux pumps, tight 
junctions and the presence of digestive enzymes. The effect of chitosan on 
permeability and enzymatic activity has been investigated with regard to the oral 
administration of proteins, which are usually too complex to be absorbed in their 
active form. Proteins must be digested and broken down into single amino acids 
or di/tri peptides in order to be absorbed by normal intestinal mechanisms (5). 
Chitosan may improve protein permeability by providing the option of paracellular 
transport through tight junctions. These junctions are close contacts between the 
plasma membranes of adjacent cells and are made up of at least 40 proteins, 
including the claudin, adherin, and occludin families of proteins. 
Tight junctions allow the passage of small molecules, with the claudin proteins 
known to form a system of 4 angstrom radius pores. However, molecules larger 
than 4 angstrom have been found to pass through tight junctions, and an upper 
limit has not been ascertained (58). 
A commonly used tool to measure permeability is transepithelial electrical 
resistance (TEER). Fromter and diamond have shown in studies using gall bladder 
epithelium, that a low TEER reading is suggestive of higher permeability or ‘‘leaky’’ 
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epithelia as termed by the authors, whereas high TEER readings suggest ‘‘tight’’ 
epithelia or low permeability (59). 
Dodane et al. provided evidence of a general mechanism of action for chitosan’s 
permeability enhancing effect at tight junctions. The authors investigated the 
effect using confocal microscopy and measuring the change in the fluorescent 
intensity for stained tight junction proteins, with only subtle decreases in intensity 
for tight junction proteins, clearer results show the redistribution of F-actin; a 
protein known to be involved in paracellular transport when using intestinal 
epithelia monolayers. Within the same study, the reversibility of the tight junction 
opening was evaluated, with TEER values returning to normal after 24 hours. The 
recovery was also tested in the presence of a protein synthesis inhibitor, which 
when present resulted in the prevention of complete recovery of TEER values (60).    
Kotze et al. studied the effect of chitosan hydrochloride on the permeability of 
Caco-2 (human colorectal carcinoma) cell monolayers, using TEER measurements. 
Results showed an 80% reduction in TEER after 20 minutes of exposure, the study 
also showed that chitosan increased the transport of radio labelled mannitol 
(usually practically impermeable) by approximately 30 fold compared to a mannitol 
control. 
Using a similar method, the same group investigated the permeability enhancing 
effect of chitosan for a group of peptide drugs, including buserelin and insulin. Both 
cases resulted in increases in transport; buserelin transport was increased from 
0.04% to 4.3% of the dose. Insulin transport was increased from undetectable 
levels to 1.2% of the dose. 
Another aspect covered in the study was whether chitosan could inhibit the 
enzymatic activity of α-chymotrypsin, thereby providing a measure of protection 
to the peptides or proteins. In the presence of the enzyme, the transport of 
buserelin was found to decrease from 4.3% to 1.3%, showing that chitosan was 
unable to protect against enzymatic degradation (32). 
In a test of two other enzymes, trypsin and carboxypeptidase B; chitosan was 
found to actually hasten the degradative process, as evidenced by the increased 
breakdown of the enzymes’ respective test substrates, benzoyl argininge 
ethylester and hippuryl-L-arginine (61). 
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This lack of enzymatic inhibition or protection, is one of the limitations of chitosan 
in the delivery of proteins, but the most obvious limitation is that, as a weak base 
with a pKa of ≈6.1 (62) the ionisation and solubility of chitosan in the acidic 
environment of the stomach is high, meaning that any chitosan/drug (or protein) 
complex would be subject to a rapid release or burst effect in the stomach. 
Conversely, in the intestine chitosan will lack or have reduced ionisation and 
solubility, and will be unable to interact with the mucous membrane, this would 
severely hinder attempts to deliver highly sensitive compounds, such as proteins. 
These limitations led to research into modified versions of chitosan via thiolation, 
carboxymethylation and quaternisation (63). 
Thiolated chitosan was developed to produce a stronger source of adhesion 
between chitosan and the mucous membrane; stronger than the ionic interaction 
seen as the source of unmodified chitosan’s mucoadhesive properties. The 
thiolated derivatives are believed to form covalent disulphide bonds through 
thiol/disulphide exchange reactions with the cysteine rich mucous membrane 
glycoproteins. Furthermore, crosslinking within the polymer itself leads to further 
entanglement and adhesion to the mucous membrane. There have been a number 
of derivatives synthesised, including chitosan thiobutylamidine, chitosan 
thioglycolic acid (Figure 1.4), and chitosan glutathione (64). 
 
Figure 1.4 Chemical structure of chitosan thioglycolic acid. 
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Schnürch et al. examined the difference in mucoadhesion between unmodified 
chitosan, chitosan thiobutylamidine, and chitosan thioglycolic acid, by attaching 
flat tablets of each sample to a section of intestinal porcine mucosa which was 
then agitated in a dissolution apparatus at specific pH and revolutions per minute. 
The samples, which were then observed for a period of one week showed a 140-
fold improvement in mucoadhesion for the thiobutylamidine derivative, and a 5-
fold increase for the thioglycolic acid derivative when compared to the unmodified 
control (65). This study shows that thiolation can be an effective option in 
increasing the mucoadhesive properties of chitosan. 
Dongwon et al. produced nanocomplexes of chitosan thioglycolic acid (as well as 
unmodified chitosan) with a DNA plasmid, by a simple mixing procedure. The goal 
of this study was to investigate the ability of the thiolated polymer to introduce 
plasmids to cells (transfection), but the study also included a cytotoxicity MTT 
assay using human embryonic kidney cells that showed that the thiolated 
derivative produced no cytotoxicity, in a result similar to the unmodified chitosan 
nanocomplexes. 
The mucoadhesion of the nanocomplexes were investigated using a technique 
involving mucin in solution, mixed with the nanocomplexes, and measuring the 
amount adsorbed over 8 hours. Results showed a small improvement in 
mucoadhesion. The ability of the complexes to protect the plasmid from the 
enzyme DNase-1 was investigated and found able to provide some protection to 
the plasmid, although not as effectively as the unmodified sample (66). 
A number of carboxymethyl chitosan derivatives have been developed through the 






Figure 1.5 Chemical structure of N-Carboxymethyl chitosan. 
de Abreu et al. synthesised samples of N,O-carboxymethylchitosan by reacting 
unmodified starting material with excesses of monochloroacetic acid and sodium 
hydroxide in 2-propanol, with higher excess leading to greater degrees of 
carboxymethyl substitutions. The solubility of the samples was compared to 
unmodified chitosan using UV/Vis spectroscopy transmittance readings. Results 
showed that the greater the number of substitutions, the greater the solubility. All 
samples showed better solubility than unmodified chitosan at higher pH (>7.2), 
this was attributed to the carboxymethyl substitutions imparting a negative charge 
along the polymer chain at pH >4 (67), this work shows that carboxymethylation 
is a valid technique to increase the solubility of chitosan in conditions of increased 
pH (ex: the duodenum). 
Thanou et al. synthesised N-carboxymethylchitosan by the addition of glyoxylic 
acid followed by sodium borohydride to produce a mono substituted derivative. 
The group tested the safety of the polymer by incubation with Caco-2 cells and 
microscopically assessing any change in cellular integrity, results showed no 
cytotoxic evidence. The samples were tested in vitro (using Caco-2 cells) to 
determine their ability to reduce TEER; as a measure of permeability 
enhancement. It was observed that the samples were able to reversibly reduce 
TEER. The group followed this with both in vitro and in vivo tests for the intestinal 
delivery of heparin, using Caco-2 cell line and Wister rats respectively. 
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In both cases, heparin transport across epithelia was increased compared to 
controls, with the in vivo test showing a 7-fold increase in bioavailability and 
concentrations achieving, and being maintained, within the therapeutic range for 
up to 3 hours (68). 
Quaternisation of chitosan involves the introduction of a permanent positive charge 
to the amine groups of the backbone; with a view to increasing the solubility of 
chitosan in neutral and basic pH. The most common example of quaternisation is 
trimethylchitosan (TMC) (Figure 1.6). The degree of quaternisation can be 
manipulated to a certain extent. 
 
Figure 1.6 Chemical structure of N-trimethyl chitosan. 
Sieval et al. was able to produce TMC using a number of techniques, achieving up 
to 80% quaternisation of amine groups (69). Although, the steps required to 
achieve this level of quaternisation, actually led to a reduction in solubility due to 
concomitant methylation of the hydroxyl group at the position 6 carbon in the 
chitosan structure. 
Thanou et al. investigated the effect of TMC on TEER, as well as its ability to 
enhance the transport of mannitol across Caco-2 intestinal cell lines. Results 
showed a concentration dependant reduction in TEER (reversibility was not 
measured in this paper), as well as an almost 20-fold increase in mannitol 
transport compared to control. The cytotoxicity was tested by incubating Caco-2 
cells with polymer samples for 4 hours and measuring their ability to exclude 
propidium iodide, with results showing no signs of toxicity. Despite there being no 
reversibility data, the cell lines used for the TEER test were washed and assessed 
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for their ability to exclude trypan blue dye as a sign of maintained cellular integrity. 
Results showed no uptake of the dye, signifying no cellular damage (70). 
The degree of quaternisation appears to have an effect on TEER reduction and 
permeability, as shown by Kotze et al. the group compared TMC with a degree of 
quaternisation of 12.6% with a sample at 19.9% quaternisation. Results showed 
greater reductions in TEER and improved transport of mannitol and polyethylene 
glycol 4000 across Caco-2 cell monolayer (71). 
Hamman et al. used an in vivo test of rat nasal epithelia with a wide range of 
quaternisation (12-59%), it was found that the ability of TMC to enhance the 
permeability of mannitol increased with greater degrees of quaternisation up to a 
point, 48%, above which no additional improvement in permeability was detected, 
this was attributed to a steric effect due to added methyl groups (72). 
Jintapattanakit et al. produced a PEC of TMC and insulin by mixing equal volumes 
of the two components at different ratios under gentle stirring. The stability of the 
PEC in different temperature environments was tested, the PEC being found to 
protect insulin for at least 6 hours, even at 50°C, compared to control. 
Investigations of enzymatic protection were carried out using a solution containing 
trypsin, with the PEC providing a measure of protection compared to insulin alone. 
Enzyme inhibition was investigated as the method of TMC protection of insulin, but 
the polymer was found to have no effect on the trypsin substrate benzoylarginine, 
this led the authors to assume a shielding effect on insulin being the most likely 
source (73). 
Currently, the use of chitosan in drug delivery especially as part of a PEC, is still 
far from efficient, often requiring many-fold the dose of standard treatment, to 
result in minute increases in bioavailability.      
1.3.1.2 Alginate 
Alginate is a natural anionic PE, its low cost and abundance have led to its mass 
production and wide use in a variety of enterprises, including the pharmaceutical, 
medical, industrial and food industries (74).  
Alginate is mainly obtained from brown algae (seaweed) by a process of alkaline 
extraction and filtration (75), although there is also a bacterial biosynthetic 
23 
 
pathway which may produce more precise chemical forms of alginate as its 
applications expand (76). 
The chemical structure of alginate is that of a polysaccharide made up of blocks of 
two different units, α-L-guluronate (G) and β-D-mannuronate (M) linked by (1, 4) 
glycosidic linkages. The alginate polymer is randomly made up of continuous 
blocks of G units, continuous blocks of M units, as well as sections of alternating 
blocks of G and M units (74, 75) (Figure 1.7). The content of different alginate 
formulations regarding the G and M units varies depending on the source of raw 
material, the stipe (stem or stalk) of the algae Laminaria hyperborea is a source 
of high G unit alginate, compared to Laminaria japonica which has a greater 
percentage of M unit blocks in its product. The relative amounts of G or M units in 
a sample of alginate can greatly affect its properties; this is demonstrated in 
alginate’s characteristic gelling property. Alginate is known to form a gel when 
exposed to certain stimuli, with a low pH environment or the introduction of 
divalent cations, such as calcium or zinc causing cross-linking of the alginate 
polymer. The G unit is thought to be of considerable importance in the cross-linking 
process, Haug (1959) was able to determine that the guluronate residue possessed 
greater affinity than mannuronate for calcium in a calcium-potassium ion exchange 
procedure. This has been attributed to the different stereochemistry of the two 
units (74, 77). 
The physical properties of the gels are also affected, with G unit rich alginates 
forming stronger more rigid gels compared to softer, slurry-like gels produced 











Alginate is soluble in water at room temperature and has pKa values of 3.65 for 
the G unit and 3.38 for the M unit (79). 
Alginate presents a number of interesting properties with regard to drug delivery; 
such as biocompatibility and low toxicity (34), as shown by Orive et al. who 
compared alginate solutions of varying compositions (regarding G and M units) 
and viscosities and purities, and monitored their effect on murine splenocytes. As 
well as investigating whether alginate led to the release of pro-inflammatory 
tumour necrosis factor (TNF-a) from murine peritoneal macrophages. In the cases 
where biomedical grade alginates were used, results showed no adverse effects or 
inflammation irrespective of composition (80).  
Bernkop-schnürch et al. analysed the mucoadhesion of alginate in tensile studies 
by compressing alginate into tablets and fixing the tablets to glass tissue mounted 
porcine mucosa, they were then pulled apart at a set rate, with results of maximum 
detachment force and total work of adhesion collected and interpreted by software, 
providing a quantitative measurement of adhesion for alginate (81). 
Although alginate cannot be digested enzymatically by mammals, it undergoes 
chemical degradation quite readily. Alginate undergoes a process of degradation 
at any pH<5 or >10 by proton catalysed hydrolysis and beta-alkoxy elimination 
respectively, as well as being prone to oxidative-reductive depolymerisation in the 
presence of free radicals (82). 
Alginate gel beads as well as micro and nanoparticles for the delivery of drug 
molecules and proteins, have been widely covered in the literature (83). However 
the use of alginate, without gelation, in forming electrostatic complexes with 
medicinal compounds is less common. Klemmer et al. produced a pea 
protein/alginate complex through simple coacervation with a view to investigating 
the effects of pH and mixing ratios on complex formation, as well as looking at any 
changes in the secondary structure of the protein. Using Raman spectroscopy the 
group found no significant changes in composition with regard to α-helix and β-
sheet content before and after complexation with alginate (84). This provides some 




A more common practice is to combine alginate with a cationic PE such as chitosan. 
Douglas and Tabrizian prepared complexes of chitosan and alginate and studied 
the effect of pH, molecular weight, and component ratios on particle formation. 
Results showed the smallest particle sizes at ratios of 1.5:1 and 1:1.5 with any 
increase in either component leading to greater particle sizes, increasing the 
molecular weight of starting material (especially chitosan) also led to greater 
particle size, although the effect was less significant than changing ratios. The 
authors showed that a pH of 5.1-5.7 was the optimal range for interaction between 
ionisable groups that produced samples with the smallest particle sizes. 
The effect of the absence of calcium ions (used in the pregelation of alginate) was 
investigated and found to result in slightly larger particle sizes, with broader size 
distributions (85). 
Sarmento et al. produced PECs of alginate and chitosan using two methods, 
chitosan added drop wise to calcium chloride pre-gelled alginate, and simple 
coacervation by the addition of chitosan solution to alginate solution, the resultant 
particles underwent size analysis using photon correlation spectroscopy, with the 
coacervation PEC resulting in average particle sizes of around 500nm compared to 
850nm for the gelation method, the morphology of the particles was studied by 
electron microscopy and showed smooth spherical particles in the gelation method 
whereas coacervation led to amorphous, porous particles. The same study 
investigated the incorporation of insulin into both types of nanoparticle, with 
similar loading results in both cases. The release of the protein was evaluated in 
vitro in simulated gastric and intestinal pH environments. Results showed that the 
coacervation nanoparticles released all incorporated insulin in a burst effect within 
the first 5 minutes regardless of the environment. The pregelation nanoparticles 
also produced a burst effect, but to a lesser degree, that was followed by a slow 
release of the protein over two hours (86). The same group investigated the 
secondary structure of insulin post incorporation into nanoparticles produced by 
the pregelation method. The protein was analysed by FTIR and circular dichroism 
(CD) following incorporation into the nanoparticles, as well as after release from 
the particles. Results showed no structural changes with regard to α-helices and 
β-sheets, which may be a sign of maintenance of biological function (87). 
27 
 
The bioactivity of insulin was confirmed to a degree when the group studied the 
effect of intra-gastric administration of alginate/chitosan insulin loaded 
nanoparticles. Streptozotocin induced diabetic male Wister rats were used to test 
for hypoglycaemic efficacy. Plasma glucose levels after administration of various 
nanoparticle/insulin doses were compared with standard subcutaneous insulin 
control, the PEC nanoparticles were shown to reduce glycaemia by up to 40% and 
maintained a hypoglycaemic effect for over 18 hours, the nanoparticles were able 
to increase the bioavailability of insulin from 1.6% to 6.8% (88). While a promising 
result, the dose required to achieve these results was 20 times greater than the 
subcutaneous dose, suggesting changes may be needed in order to improve 
efficacy. 
Li et al. synthesised PEC nanoparticles of alginate and quaternised chitosan, and 
studied their ability to encapsulate the protein albumin. The potential for 
electrostatic interaction between the two components was shown using Fourier 
transform-infra-red spectroscopy (FT-IR), with changes in the frequency and 
intensity of charge carrying groups in the spectra of alginate, Quaternised 
chitosan, and alginate/Quaternised chitosan nanoparticles.  
The group showed that increasing the molecular weight of chitosan used, led to 
greater nanoparticle size, whereas increasing the degree of substitution of the 
charge bearing N-propyltrimethyl ammonium, showed no significant effect on 
particle size. 
The effect of molecular weight and the degree of substitution on the entrapment 
of albumin in the complex was investigated, and showed a trend of increasing 
encapsulation efficiency of albumin with increasing molecular weight and degree 
of substitution. Increasing the initial concentration of albumin or that of chitosan 
improved encapsulation efficiency, but only to a point, above which no additional 
improvement was measured. In the case of increasing molecular weight, improved 
encapsulation was attributed to increased particle size, while the improvement 
seen with increased substitution was associated with the increased abundance of 
positive charges, leading to more interactions with the negative functional groups 
of albumin. 
The release of albumin from nanoparticles was studied in vitro using different pH 
environments. In the simulated gastric pH, results showed a slow release of 
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albumin (20% over 100 hours), whereas at pH 7.4, a burst effect was evident with 
60% release after 12 hours followed by slower release. The burst effect was 
attributed to the disintegration of the alginate component of the nanocomplex. 
In the acidic pH environment, lower molecular weight chitosan showed slower 
release patterns, which was, according to the authors, due to the low molecular 
weight chitosan diffusing more easily in the pre-gelled alginate, leading to the 
formation of thicker complexes that slowed the release of albumin. 
The effect of degrees of substitution on release showed clear results, with 
increasing substitution leading to decreased protein release in both pH 
environments. Increased electrostatic interaction between PEC components was 
seen as the cause of the slower release pattern (89).    
1.3.2 Amphiphilic polyelectrolytes 
Amphiphilic PEs contain hydrophilic and hydrophobic groups in their structure, 
these PE were developed to make use of the potential benefits of the addition of 
hydrophobicity to drug delivery agents, including a possible increase in 
hydrophobic interaction with epithelial cells of gastrointestinal or nasal tissue, 
which may increase the likelihood of absorption, as well as increased interaction 
between components of a PEC, to complement the pre-existing electrostatic 
interaction. 
The effect of increasing hydrophobicity was investigated by Mende et al. who 
synthesised sets of oppositely charged maleic anhydride polymers; the 
hydrophobicity of the PEs was controlled through the addition of increasingly 
hydrophobic grafts, ethylene, isobutylene, or styrene. 
The group studied the effect on colloidal stability, size, and morphology of the 
resultant PEC. The samples with the greatest hydrophobicity, the styrene grafted 
PE, showed the broadest particle size distribution, with size and structure studies 
indicating the formation of large aggregates as well as small, distinct, dense 
particles. The increase in hydrophobicity also led to lower colloidal stability, with 
styrene samples precipitating after 5 hours (90). 
Broderick et al. synthesised an amphiphilic derivative of alginate by covalently 
linking butanol to alginate via esterification. The resulting polymer was found to 
have maintained the gelling property of alginate, as well as the low toxicity of 
29 
 
unmodified alginate (91). Liqun et al. synthesised a cholesteryl grafted alginate 
polymer, using dicyclohexylcarbodiimide as a coupling agent, the resulting 
amphiphilic PE was investigated and found to self-assemble into particles in 
aqueous solution. The particle size and morphology were analysed; with results 
showing the consistent formation of spherical particles in the range of 100-200nm 
(92). 
1.3.2.1 Hydrophobically Modified Chitosan 
Wang et al. synthesised hydrophobically modified chitosan to investigate its effect 
on the oral absorption of enoxaparin, a low molecular weight heparin used in the 
prophylaxis and treatment of deep vein thrombosis, enoxaparin carries a strong 
negative charge and has poor oral bioavailability. Glyceryl monostearate, the fatty 
acid components of which had previously been shown to display a degree of 
interaction with rat intestinal sections, was grafted onto the chitosan backbone 
with varying degrees of substitution. Following the addition of enoxaparin, the 
polymer and drug self-assembled into nanocomplexes. 
The effect of the degree of substitution of glyceryl monostearate on particle size 
was found to be minimal when low percentages of grafted substituent are used. 
Particle sizes showed similar results to unmodified chitosan based nanoparticles, 
although an increase in particle size was seen as the percentage graft increased; 
this was attributed to a reduction in positive charge density leading to weaker 
electrostatic interaction with enoxaparin. 
In vitro release studies of amphiphilic PEC in simulated gastric and intestinal 
conditions showed limited release at gastric pH, while at intestinal pH the release 
results were similar for all samples tested, including unmodified chitosan control, 
indicating no significant effect on release by the addition of hydrophobic moieties. 
The in vivo absorption of amphiphilic chitosan was studied in rats, by administering 
nanocomplexes directly into the stomach. The bioavailability of administered doses 
was then measured against an intravenous injection of enoxaparin. Results showed 
that bioavailability increased with increasing graft percentage, up to a certain point 
above which no additional increase was seen. In total the group was able to 
increase the bioavailability of oral enoxaparin from 1.34% to 12.96% (93). This 
shows that the addition of hydrophobic elements to some PECs may be extremely 
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useful in increasing the interaction with gastrointestinal epithelia and possibly 
enhancing absorption of typically poorly absorbable compounds. 
1.3.2.2 Lactide-Polyvinyl Alcohol Copolymers 
Simon et al. synthesised PECs using lactide and diethylaminopropylamine grafted 
polyvinyl alcohol backbone with insulin. The resulting self assembled particles were 
measured for size and found to be in the range of 200-400nm. Morphology studies 
showed smooth spherical particles. A higher degree of grafting of either component 
was found to result in decreased particle size, and increased binding and loading 
of insulin, the influence of electrostatic interactions appeared to be greater than 
that of increasing hydrophobicity, the authors, using turbidimetric studies, found 
that turbidity decreased with increasing diethylaminopropylamine concentration, 
this decrease was attributed to the formation of more compact structures, the 
observed effect was significantly less in tests of increasing lactide grafts. The group 
also used isothermal micro-titration calorimetry to show the degree of interaction 
between different PE compositions and insulin. Using this technique, results 
showed a similar increase in binding constants of both graft components as the 
degree of substitution was increased, despite this, the gained entropy from the 
liberation of counter ions was deemed the most important factor in complex 
formation (94). 
The same group investigated the effectiveness of their PEC in delivering insulin 
nasally and orally; the bioavailability of nasally administered nanoparticles was 
tested in vivo, using streptozotocin induced diabetic rats, nanoparticle suspensions 
were delivered directly to the nostrils of anesthetised rats, with blood samples 
taken and compared to subcutaneous injections of insulin and free insulin solution. 
PECs with greater hydrophobic grafting provided greater hypoglycaemic effect, 
with plasma glucose reductions of over 20%, which corresponded to a 
bioavailability of 7.7%, compared to less than 1% for free insulin solution (95). 
In studies towards oral delivery, the group studied the effect of the nanocomplexes 
on enzyme degradation, cytotoxicity, and transport across Caco-2 cells. 
Nanoparticles were analysed in solutions of the enzyme trypsin, and found to 
provide protection for complexed insulin. The level of protection was found to be 
greater with increased lactide grafting. 
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In vitro cytotoxicity was assessed by incubating Caco-2 cells with the PEC and 
monitoring the release of lactate dehydrogenase (LDH), a cytosolic enzyme used 
as a marker for cellular damage, the results showed increased LDH concentrations 
with higher lactide grafting. 
Cellular uptake and transport was investigated using Caco-2 monolayers, with 
results showing that less than 1% of the initial insulin dose in the PEC was 
transported across the monolayer, whereas cellular uptake, whether of released 
insulin or the complexes as a whole, increased the amount of internalised insulin 
from less than 1% (control) to 25% of initial insulin dose, the percentage was 
found to increase with increasing hydrophobic grafting (96). 
Highly lactide grafted samples also showed the highest reductions in TEER during 
cellular transport studies but the reduction was found to be completely reversible 
by 17 hours after removal of the sample, and by 26 hours TEER was recorded as 
>200% of initial readings. The authors attributed this to the reorganisation of tight 
junction proteins following cellular damage. 
This shows that further research is required to improve levels of paracellular, and 
transcellular transport if they are to be relied upon to achieve therapeutic levels, 
as well as economic and efficient doses. It would seem that the addition of 
hydrophobic groups resulted in increased interaction between nanocomplexes and 
the cell membrane of epithelial cells. 
1.3.2.3 Hydrophobically Modified Poly (allyl amine) 
Thompson et al. showed the effect of hydrophobicity on the self-assembly products 
of the PE poly (allyl amine). The group synthesised cetyl, palmitoyl (Figure 1.8) 
and cholesteryl derivatives of poly (allylamine) and studied a number of 
characteristics, including the critical aggregation concentration (CAC), particle 




Figure 1.8 Chemical structure of palmitoylated poly(allyl amine). 
Results showed that the more hydrophobic groups produced lower CAC values as 
well as smaller average particle size. Electron microscopy results showed that the 
highly hydrophobic cholesteryl derivative produced dense nanoparticles, whereas 
the derivatives with groups possessing less hydrophobicity; namely pamitoyl and 
cetyl, resulted in nanoparticles and micelles respectively (29). 
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The same group followed up their work by incorporating amphiphilic PEs, as well 
as the quaternised polyallylamine version of each, in the formation of PECs with 
insulin, these complexes were studied for size, stability, and morphology. It was 
shown that as the ratio of polymer to insulin was increased, the average size of 
complexes decreased from over 1 micron with lower concentrations of polymer, to 
around 150nm when the ratio of the amphiphile was greater. Electron microscopy 
showed that morphology was dependant on polymer/insulin ratio, with higher 
polymer ratios leading to dense nanoparticles, while vesicular structures were the 
result of lower polymer ratios. 
In order to measure the stability of the PEC, samples underwent centrifugation; 
the subsequent supernatant was measured for zeta-potential, which showed that 
the amphiphilic polymer and the insulin remained in complex, as the pre and post 
centrifugation readings were similar. 
Studies on enzymatic degradation of insulin in vitro showed that the palmitoyl 
based PEC was able to provide the protein with a degree of protection from trypsin 
and pepsin, but led to a more rapid degradation in the presence of α-chymotrypsin. 
Furthermore, the cetyl and cholesteryl based PEC provided protection against 
trypsin and α-chymotrypsin, but not pepsin. Indicating that perhaps a combination 
of polymers may be able to provide the necessary range of enzymatic protection 
required to overcome this particular barrier to oral delivery of proteins and 
peptides. 
In cytotoxicity studies using an MTT assay of Caco-2 cells incubated with samples, 
the amphiphilic samples were found to have greater IC50 values than the 
unmodified polyallylamine, showing the reduced toxicity of the amphiphilic 
derivatives, especially the palmitoylated derivative which exhibited a 3 fold 
decrease in cytotoxicity compared to the original compound (97). 
Uptake of palmitoylated amphiphilic PE/insulin nanocomplexes by Caco-2 cells was 
performed either in the presence of the metabolic inhibitor sodium azide, or the 
endocytosis inhibitors cytochalasin D and nocodazole. 
The effect of the presence of calcium on uptake was also evaluated. Results 
showed that the palmitoylated PEC became localised around the cell membrane 




The quaternised palmitoyl PEC was found to be localised in the cytoplasm 
regardless of the presence of calcium or the endocytosis inhibitors, with only 
sodium azide showing a small negative effect on uptake, indicating the 
involvement of a metabolically active process of uptake with the quaternised PEC. 
The transport of palmitoyl PECs across Caco-2 cells was studied using Transwell 
plates, and measuring samples of the basal compartment media for the presence 
of insulin. The TEER of the Caco-2 cells was also measured. 
Results showed TEER reductions of 15% from baseline for the palmitoyl PEC, and 
25% for the quaternised PEC, indicating paracellular transport. Complementing 
this was the data from the concentration of insulin in the basal compartment; 
which showed higher concentrations than control (insulin alone), with quaternised 
palmitoyl nanocomplexes showing the highest percentage of transported insulin. 
Although the percentage transported amounts to less than 1% of the insulin dose 
used (98). A significant increase in the percentage of transported insulin would be 
necessary, if PECs were to be seen as a possible option for oral protein delivery. 
1.4 Aims and objectives 
The aim of this work was the investigation of the electrostatic complexation of 
palmitoyl grafted poly(allyl amine) amphiphilic polymers, and the oppositely 
charged hydrophilic polymer sodium alginate. This was followed by the 
incorporation of insulin into the complex and analysis of the effect of the 
combination on the enzymatic activity of α-chymotrypsin towards the insulin 
molecule. 
The objectives of this work included: 
 Synthesis and characterisation of amphiphilic and quaternised poly(allyl 
amine). 
 Preparation and characterisation of polyelectrolyte complexes using 
synthesised poly(allyl amine) derivatives and sodium alginate. 
 Incorporation of insulin into alginate/poly(allyl amine)/insulin complexes, 
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2. Polymer synthesis and characterisation 
This chapter focuses on the synthesis of amphiphilic and quaternised derivatives 
of poly(allylamine) with a view to investigating their ability to interact with sodium 
alginate (chapter 3), and towards formulating an amphiphilic polyelectrolyte 
complex with insulin (chapter 4). 
The synthesis of amphiphilic polymers involved the reaction of palmitic acid-N-
hydroxysuccinamide with primary amines of poly(allylamine). The 16 carbon 
palmitic acid chains provided an increased hydrophobic character to the polymer. 
The addition of hydrophobic groups to poly(allylamine) is known to produce an 
amphiphilic polymer with the ability to self-assemble into particles in the nano size 
range.  
Quaternisation involved the use of methyl iodide to produce methylation of free 
amines of the poly(allyl amine) backbone, the resulting permanent positive charge 
was expected to provide electrostatic interaction with sodium alginate regardless 
of pH environment, this will be discussed in more detail in chapter 3. 
Characterisation of synthesised polymers was performed in order to help confirm 
synthesis, as well as examine any clear changes in polymer properties. Techniques 
used include infra-red, thermal, and elemental analysis as well as nuclear magnetic 
resonance.      
2.1. Materials 
Poly(allylamine hydrochloride) (Mw =15000Da) (Sigma-Aldrich, UK), sodium 
hydroxide pellets, sodium hydrogen carbonate, palmitic acid-N-
hydroxysuccinamide (Sigma-Aldrich, UK), sodium iodide (Sigma-Aldrich, UK), 
methyl iodide (Sigma-Aldrich, UK), amberlite 93 resin (Sigma-Aldrich, UK), all 
other chemicals were of analytical grade and sourced from fisher scientific, UK. 
2.2. Method of polymer synthesis 
The methods of polymer synthesis are based on the work of Thompson et al (1). 
2.2.1. Conversion of poly(allylamine hydrochloride) to poly (allylamine) 
free base. 
Poly(allylamine hydrochloride) (10g) was dissolved in (100mL) of distilled water. 
The pH of the solution was then adjusted to approximately 13, this was followed 
by dialysing the solution against (5L) of distilled water using 7kDa molecular 
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weight cut-off dialysis bags; water was changed 6 times over 24 hours. Dialysate 
was then lyophilised over 72 hours using a freeze drier (VirTis advantage, 
Biopharma Process Systems, UK) to obtain a dry, white solid. 
2.2.2. Synthesis of amphiphilic polymers 
The objective of palmitoyl (PA) grafting was to synthesise 2.5% and 5% 
substituted poly(allylamine) (pa2.5 and pa5), the method of synthesis is identical 
except for the molar feed ratio of palmitic acid-N-hydroxy succinamide. 
Poly(allylamine) free base (1000mg) and sodium bicarbonate (1176mg) were 
dissolved in 100mL distilled water. Palmitic acid-N-hydroxy succinamide ester 
(304mg for pa2.5 or 608mg for pa5) was dissolved in 100mL ethanol. 
The palmitic acid ester solution was added drop-wise to the round bottomed flask 
containing poly(allylamine), the flask was then stoppered and the reaction left 
under magnetic stirring for 72 hours at room temperature. 
Solution was dialysed against 5L distilled water, using 12-14kDa molecular weight 
cut-off dialysis bags. Water was changed 6 times over 24 hours. Dialysate was 
lyophilised over 72 hours to obtain dry, white solid. 
2.2.3. Synthesis of quaternised amphiphilic polymers 
Quaternisation was performed on pa2.5 and pa5, leading to the synthesis of 
quaternised pa2.5 (Qpa2.5) and quaternised pa5 (Qpa5).  
Amphiphilic polymer (600mg), sodium hydroxide (557mg), and sodium iodide 
(250mg) were dissolved in 100mL methanol. Methyl iodide 3.51mL was added to 
the solution. The reaction was carried out under nitrogen environment at 36°C for 
3 hours. 
The resulting precipitate was separated from the solution. Diethyl ether 400mL 
was added to the precipitate, while a further 200mL diethyl ether was added to 
the separated solution to enhance precipitation of any leftover product. Both 
suspensions were then left to dry overnight under a fume hood. 
An ethanol and water (1:1) stock was prepared and used to dissolve the dried 
precipitate. Solutions were dialysed against 5L distilled water using 12-14 kDa 
molecular weight cut-off dialysis bags. Water was changed 6 times over 24 hours. 
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Dialysate was then passed through an amberlite ion exchange column. The column 
was prepared by washing with 2M hydrochloric acid (100mL) followed by regular 
washing with distilled water until neutral pH was recorded. 
Ion exchanged dialysate was then lyophilised over 72 hours to produce dry, 
white/off white solid. 
2.3. Polymer characterisation 
2.3.1. Elemental analysis and proton nuclear magnetic resonance 
Elemental analysis of synthesised polymers pa2.5, pa5, Qpa2.5 and Qpa5 (20mg 
of each) was carried out to determine the relative abundance of carbon, nitrogen, 
and hydrogen, as well as chlorine in the case of quaternised samples. Data was 
obtained using a Perkin Elmer 2400 Series II CHNS analyser (Perkin Elmer, UK) 
Polymer structure was investigated using 1H-NMR. PAA, pa2.5, pa5, Qpa2.5 and 
Qpa5 (15mg of each) were sonicated in deuterated methanol (1-2mL) and inserted 
into a BRUKER 400MHz ultrashield spectrometer (Bruker, USA); TOPSPIN 1.3 
software was used to acquire and annotate sample spectra. 
2.3.2. Infra-red analysis 
Infra-red analysis (IR) was carried out on samples of PAA, pa2.5, pa5, Qpa2.5 and 
Qpa5 using a Thermo Nicolet IR spectrophotometer (Thermo Fisher Scientific, 
USA) using diamond tip accessory. Measurements were performed at 32 scans per 
spectrum between 4000-500cm-1. Data was analysed using OMNIC software.    
2.3.3. Thermal analysis 
Differential scanning calorimetry (DSC) was used to investigate the thermal 
properties of the polymers to be used in complex formation. Data was acquired 
using a Q100 differential scanning calorimeter (TA instruments, UK). Samples of 
PAA, pa2.5, pa5, Qpa2.5, and Qpa5 (1-5mg) were run over a temperature range 
of 0-300°C at 20°C/minute under nitrogen atmosphere. The instrument was 
calibrated with an indium standard. 
LEICA DFC 420 digital microscope (LEIKA, Germany) coupled to a LINKAM LTS 350 
hot-stage (Linkam scientific instruments, UK) was used to capture images of PAA, 
pa2.5, pa5, Qpa2.5, and Qpa5 at temperature points from room temperature to 
300°C at 20x magnification. 
48 
 
Thermogravimetric analysis (TGA) was carried out on PAA, pa2.5 and pa5 using a 
Q500 thermogravimetric analyser (TA instruments, UK) in order to study the 
amount of weight change as a function of increasing temperature. This data was 
used in conjunction with DSC and hot-stage images in order to assist in the 





















2.4. Results and discussion 
2.4.1. Elemental analysis and NMR for synthesis validation 
The NMR spectrum of PAA (Figure 2.1) shows two groups of peaks; the first at 1.0-
1.7ppm designated (A) corresponds to the protons of the polymer backbone. The 
second set of peaks at 2.4-2.8ppm, designated (B) corresponds to the protons 
adjacent to the electron withdrawing amine. 
The NMR of pa2.5 (Figure 2.2) and pa5 (Figure 2.3) are very similar, and will be 
discussed together. The signal at 0.8ppm, signal (A), is attributed to the terminal 
methyl group of palmitic acid chains. The peaks from 1.0-1.5ppm (B) are due to 
overlapping signals from polymer and palmitic acid backbone protons. The signal 
at 2.2ppm designated (C) was attributed to protons next to the carbonyl of palmitic 
acid graft. The peak at 2.5ppm (D) was attributed to the protons adjacent to amine 
groups of the polymer backbone (2). 
The degree of palmitic acid substitution along the PAA backbone was estimated 
using NMR data. The terminal methyl was used to estimate the percentage graft 
of palmitic acid, by comparing the integral at point (A) with the integral at point 
(D) (Equation 2.1). 
%𝐺𝑟𝑎𝑓𝑡𝑖𝑛𝑔 = ((
𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑙 𝑜𝑓 𝐴
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑟𝑜𝑡𝑜𝑛𝑠 (𝐶𝐻3)
) ÷ (
𝐼𝑛𝑡𝑒𝑔𝑟𝑎𝑙 𝑜𝑓 𝐶
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑝𝑟𝑜𝑡𝑜𝑛𝑠 (𝐶𝐻2)
)) × 100% 
Equation 2.1 Estimating %graft of palmitic acid-N-hydroxysuccinamide using 1H-
NMR. 
The NMR spectra of Qpa2.5 (Figure 2.4) and Qpa5 (Figure 2.5) were not used in 
the estimation of quaternisation, due to the overlapping signals of protons adjacent 
to amines and quaternary ammonium, shown in the figures as (C) and (D) 
respectively, in both cases falling within the region of 2.5-3.0ppm. Signals (A) and 












   
 




















Figure 2.5 1H-NMR of quaternised 5% pa-poly(allylamine) in deuterated 
methanol. 
Elemental analysis of the amphiphilic polymers was also used in the estimation of 
hydrophobic grafting by measuring the relative increase of carbon, in comparison 
to poly(allyl amine), in the amphiphilic polymer samples; it was assumed that the 
source of additional carbon must be from added palmitic acid groups. This 
assumption was seen as reasonable, due to a lack of other possible sources of 
carbon. By then approximating the number of palmitic acid units accounting for 
the carbon excess, a percentage graft can be estimated (equation 2.2). This 
method was used by Thompson et al. to estimate palmitoyl substitution of PAA 













Carbon excess = (
Abundance of carbon in amphiphilic polmer
Abundance of nitrogen in amphiphilic polymer
) − (
Abundance of carbon in PAA





) × 100% 
Equation 2.2 Estimating %graft of palmitic acid using elemental analysis. 
Table 2.1 shows the results of NMR and elemental analysis calculations for the 
amphiphilic polymers. Although results did not produce exact 2.5 and 5 percent 
grafts, the two techniques used appeared to be in agreement that pa5 did posses 
higher grafting values than pa2.5. 
Table 2.1 Estimation of palmitic acid-N-hydroxysuccinamide grafting. 
PAA derivative Estimation based on 
NMR (n=1) 
Estimation based on 
elemental analysis (n=2) 
Pa2.5 3.1% 3.7% 
Pa5 3.5% 5.1% 
 
Elemental analysis was used to estimate the degree of quaternisation by 
comparing the relative elemental abundance in quaternised samples to those of 
the non-quaternised samples. Elemental analysis has previously been used in the 
estimation of quaternisation of poly(allyl amine) (1), as well as a number of other 
polymers, such as chitosan (4), pectin (5), and poly(vinyl alcohol) (6). 
Quaternised samples presented with an increase in carbon abundance, which was 
attributed to methylation of amine groups along the Pa-PAA backbone. By 
assuming tri-methylation of primary amines (The estimation does not take into 
account the possible formation of secondary and tertiary amines), an estimated 
level of quaternisation can be calculated according to equation 2.3.  
Carbon excess = (
Abundance of carbon in quaternised polymer
Abundance of nitrogen in quaternised polymer
) − (
Abundance of carbon in amphiphilic polymer





) × 100% 
Equation 2.3 Estimating %quaternisation of amphiphilic polymers. 
Results of the quaternisation process are shown in table 2.2   
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Table 2.2 Estimation of quaternisation of amphiphilic polymers (n=1). 




It would be expected that pa2.5, which was estimated to have had a greater 
number of free amines, would undergo quaternisation more readily than pa5, as 
the addition of large hydrophobic groups may interfere with the accessibility of 
free amines (7). However, the result was the opposite. It may simply be a matter 
of errors during the synthesis process leading to incomplete quaternisation.  
2.4.2. IR analysis 
The IR spectra for PAA (Figure 2.6) exhibited primary amine stretch vibrations at 
3354cm-1, 3279cm-1, and 3181cm-1 and N-H bending vibrations at 1591cm-1. C-N 
stretching vibrations were visible at 1120cm-1. C-H stretching vibrations were 
visible at 2908cm-1 and 2848cm-1, with bending vibrations at 1448cm-1. 
 



















































































































































































































The addition of palmitic acid led to some changes to the spectrum of PAA. The 
three peaks attributed to primary amine stretching were replaced by single, 
shallow signals at 3284cm-1 and 3291cm-1 for pa2.5 and pa5, respectively; this 
may be due to palmitic acid substitution of primary amines leading to lower 
absorption. This trend was repeated at the other end of the spectrum, where 
primary N-H bending vibrations of PAA at 1591cm-1 was replaced by what appeared 
to be two amide bands at 1624cm-1 and 1560cm-1 in pa2.5, as well as 1624cm-1 
and 1558cm-1 in pa5. A similar finding was obtained by Jiang et al. who synthesised 
palmitic acid grafted chitosan, and found that the primary amine peak of chitosan 
was replaced by amide bands; this was reported even at 0.9% palmitic acid 
substitution (8). 




Table 2.3 IR bands of PAA and amphiphilic polymers. 
Polymer Vibration (cm-1) Chemical assignment 






















































Upon closer inspection of the pa5 spectrum (Figure 2.7), a signal at 1737cm-1 may 
indicate the presence of carbonyl groups of palmitic acid graft. 
 
Figure 2.7 Magnification of IR spectrum of pa5 from 2000-1400cm-1. 
Quaternised polymers showed similar spectra to their amphiphilic precursors 
(Figure 2.8). Qpa2.5 showed amine stretching vibrations at 3372cm-1, N-H bending 















































Qpa5 exhibited amine stretching at 3378cm-1, with amine bending at 1617cm-1. C-
H peaks were recorded at 2919cm-1, 2851cm-1 and 1466cm-1. 
increased absorbance of C-N stretch vibrations at 1177cm-1 and 1176cm-1 for 
Qpa2.5 and Qpa5 respectively may be due to methylation of nitrogen and 
increased abundance of C-N bonds, Snyman et al found a similar increase in 
absorption when working with quaternised chitosan (9). 
The new peaks around 960 cm-1 in the quaternised polymers were attributed to 
the quaternary nitrogen, similar peaks have been recorded in the literature, in the 
case of quaternised derivatives of methacrylate co-polymers (10), poly(vinyl 
alcohol) (11), and poly(ethyleneimine) (12, 13). 
Another new signal at 1518cm-1 in both quaternised polymers may also have some 
association with quaternary ammonium and electrostatic interaction, and will 
therefore be discussed further in chapter 3. Quaternisation also led to the 
disappearance of amide bands and the return of amine bending vibrations 
(1591cm-1 in PAA) at 1615cm-1, the cause of this is unknown.  
 



























































































































































































































































































2.4.3. Thermal analysis 
PAA showed a series of endotherms beginning at 141°C (Figure 2.9). This differs 
from results obtained by Thompson et al who found a sharp peak at 220°C that 
was attributed to melting (1). This may be caused by differences in molecular 
weight of synthesised polymers, arising from the dialysis process. Lower molecular 
weights result in lower melting points (14), therefore if the dialysis process 
resulted in a large population of low molecular weight fractions, it may explain the 
variation between these results and those of Thompson et al.  
 
Figure 2.9 DSC thermograms of PAA and amphiphilic derivatives. 
According to hot stage microscopy (Figure 2.10), melting appeared to begin at 
90°C, while 245°C was the point at which sample discolouration began. 
Discolouration was expected to represent polymer decomposition, but data from 
TGA shows only a small reduction in weight from baseline to 300°C (Figure 2.11). 
This could represent sample dehydration, although when coupled with hot-stage 
images and the failure of PAA samples to return to baseline state on cooling, or 
exhibit the same DSC peaks on reheating (Figure 2.11), it appears that some type 




Figure 2.10 Hot-stage images of PAA at magnification x20. (A) Room 
temperature (B) 90°C (C) 155°C (D) 245°C (E) 300°C (F) Cooled to room 
temperature. 
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The thermogram of pa2.5 showed an endothermic event at 141°C, followed by 
another endotherm at 171°C. When coupled with hot-stage images (Figure 2.12), 
a measure of correlation can be seen. Images appeared to show the polymer 
melting at approximately 100°C, by 155°C the thermal process appeared to be 
complete, this is in agreement with the wide DSC endotherm at 141°C. The 
widening of endotherms in comparison to PAA could be due to a less ordered 
crystalline structure with the addition of hydrophobic grafts, leading to a softening 
or melting over a relatively wide temperature range. This can be expected, as the 
addition of palmitic acid carbon chains will have hindered the ability of PAA to stack 
in an orderly crystalline arrangement, a similar reduction in crystallinity on addition 
of hydrophobic grafts can be seen in other polymers; such as lactide grafted 
chitosan (15). 
 
Figure 2.12 Hot-stage images of pa2.5 at magnification x20. (A) Room 
temperature (B) 100°C (C) 150°C (D) 200°C (E) 300°C (F) Cooled to room 
temperature. 
The second endotherm at 171°C also shows a widening effect. Although, there was 
no clear correlation with hot-stage images at the same temperature, with no 
observable change evident until approximately 210°C at which point discolouration 
of the polymer began, continuing up to 300°C. There may have been a secondary 
melt/form of crystals that went undetected by hot-stage microscopy. The second 
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endotherm may also have been due to some type of polymer degradation occurring 
prior to the observed discolouration at 210°C. 
TGA data shows approximately 33% reduction in weight up to 300°C (Figure 2.13), 
this is approximately double that of PAA. Furthermore, pa2.5 did not revert to 
original condition on cooling, or show similar DSC peaks during reheating. There 
appeared to be a permanent change in polymer structure in a result similar to PAA. 
 
Figure 2.13 Heat/cool/reheat DSC thermogram and TGA for pa2.5. 
Results for pa5 showed a wide endotherm at 146°C, attributed to polymer melting, 
followed by an exotherm at 171°C. On examination by hot stage microscopy 
(Figure 2.14); pa5 can be seen to begin melting at approximately 100°C, by 140°C 
the process appears to be complete. This shows some similarity to the wide DSC 
peak at 146°C (Figure 2.9), as well as having a resemblance to the initial 
endotherm of pa2.5, which was to be expected, as the difference in hydrophobic 















































































Figure 2.14 Hot-stage images of pa5 at magnification x20. (A) Room 
temperature (B) 100°C (C) 140°C (D) 210°C (E) 300°C (F) Cooled to room 
temperature. 
Discolouration of the sample began at approximately 200°C, similarly to pa2.5. 
Data from TGA (Figure 2.15) showed a 35% weight loss measured by 300°C, with 
DSC cooling and reheating thermograms showing that the polymer did not undergo 
the same thermal events as the first heating cycle, in a result similar to that of 




Figure 2.15 Heat/cool/reheat DSC thermogram and TGA for pa5. 
The DSC thermogram of pa2.5 presented with two successive endotherms, 
whereas pa5 showed an endotherm quickly followed by an exotherm. When 
supplemented with data from hot-stage microscopy and TGA, it appeared that both 
pa2.5 and pa5 underwent melting followed closely by degradation. 
The area under the curve of the first endotherm of pa5 (83.02J/g) was found to 
be less than that found for the first endotherm of pa2.5 (149.8J/g). This was seen 
as an indication that pa5 was perhaps less crystalline than pa2.5 which was in turn 
less crystalline than PAA. When viewed in conjunction with other results, this 
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Quaternisation of amphiphilic polymers led to a substantial change in DSC 
thermograms. As shown in figure 2.16, Qpa2.5 failed to exhibit clear thermograms 
at similar temperatures to those of pa2.5. 
 
Figure 2.16 DSC thermograms of pa2.5, pa5, Qpa2.5 and Qpa5. 
A similar result was found with Qpa5. Both quaternised polymers showed a wide 
signal around 100°C that was attributed to evaporation of bound water. 
On investigation under hot-stage microscopy (Figure 2.17), Qpa2.5 appeared to 
contract at approximately 200°C. Discolouration began at 255°C and continued up 




Figure 2.17 Hot-stage images of Qpa2.5 at magnification x20. (A) Room 
temperature (B) 100°C (C) 225°C (D) 300°C (E) Cooled to room temperature. 
In the case of Qpa5 (Figure 2.18), contraction began at approximately 220°C, 
while discolouration became evident at 240°C. The process again appeared to be 





Figure 2.18 Hot-stage images of Qpa5 at x20 magnification. (A) Room 
temperature (B) 100°C (C) 230°C (D) 300°C (E) Cooled to room temperature. 
Both Qpa2.5 and Qpa5 showed no signs of melting at temperatures similar to 
those of non-quaternised samples, or indeed over the temperature range 
measured. Quaternisation appeared to have further hindered the crystalline 
nature of PAA, leading to increased amorphous characteristics, principally the 
loss of a distinct melting point or melting range. 
In general, the thermal analysis of synthesised polymers showed a trend of 
increasing amorphous character following hydrophobic grafting and 
quaternisation. This was to be expected, as both processes introduce bulk to the 








The purpose of this chapter was to investigate the synthesis of polymers used in 
this study. 
From results of elemental analysis and NMR, it was seen that the structure of 
PAA underwent alteration; this change was attributed to the addition of palmitic 
acid grafts. 
In order to investigate the result of quaternisation; NMR was used qualitatively 
alongside elemental analysis. 
Polymers investigated using TGA showed a degree of weight loss over the 
measured temperature range. The amount of weight loss was not sufficiently 
large as to be attributed to complete decomposition. Therefore it was assumed 
that what took place was an initial loss of adsorbed water, followed by the loss of 
structural water and some form of polymer degradation, such as random or side 
group scission (16). 
The polymers discussed in this chapter were used in combination with sodium 
alginate to synthesise polyelectrolyte complexes, the results of these 
combinations will be covered in chapter 3. 
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3. Polyelectrolyte complex formation 
This chapter focuses on the investigation of the different ratios of poly(allylamine) 
derivatives and sodium alginate used in the formulation of polyelectrolyte 
complexes (PECs). 
Characterisation and analysis of resulting PECs was used to assist in the selection 
of the most stable and reproducible combinations. These would then be 
investigated further with regard to their interaction with insulin, discussed in 
chapter 4. 
Analytical techniques used include dynamic light scattering, which was used to 
estimate the average particle size of complexes in suspension, as well as the 
average polydispersity index. 
UV-visible spectroscopy together with a visual inspection was used to assess 
colloidal stability of PECs.  
Infra-red and thermal analysis were used to interpret the effect of the electrostatic 
interaction between the polyelectrolytes (PEs) in the solid state.  
3.1 Materials 
Sodium alginate (Mw= 120000-190000Da) (Sigma-Aldrich, UK), sodium 
hydroxide, and hydrochloric acid buffers were sourced from fisher scientific, UK. 
Synthesised polymers used in polyelectrolyte complex formation include pa2.5, 
pa5, Qpa2.5, Qpa5. 
3.2 Polyelectrolyte complex formation 
Polyelectrolyte complex formulation was based on the work of Sarmento et al (1); 
with a view to preparing the following complexes: alg/pa2.5, alg/pa5, alg/Qpa2.5, 
and alg/Qpa5 at a number of ratios. 
Initially, samples of cationic PEs pa2.5, pa5, Qpa2.5, Qpa5, or anionic sodium 
alginate were dissolved in distilled water 10mL (all at 0.1% w/v). Sonication for 5 
minutes at 20kHz was necessary in the preparation of solutions of cationic PEs. 
The oppositely charged PEs were then prepared at a concentration corresponding 
to table 3.1. 
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Table 3.1 Mass ratios used in the formation of polyelectrolyte complexes, and 








*alg/PE+ 4.3:1 0.1% w/v 0.0232% w/v 
alg/PE+ 3:1 0.1% w/v 0.0333% w/v 
alg/PE+ 1:3 0.0333% w/v 0.1% w/v 
*alg/PE+ 1:4.3 0.0232% w/v 0.1% w/v 
* The mass ratios of 4.3:1 and 1:4.3 were not prepared for quaternised polyelectrolytes. 
** Cationic PEs included pa5, pa2.5, Qpa5 and Qpa2.5. 
The alginate and amphiphilic PE solutions were then adjusted using 1M hydrochloric 
acid and/or sodium hydroxide, to pH 4.9 and 4.6, respectively, in order to achieve 
ionisation of component PEs. Solutions were then combined by drop-wise addition 
of the lower concentration PE solution from a burette into the PE solution of higher 
concentration over 5 minutes, under gentle magnetic stirring. Resulting solutions 
were characterised in the liquid state or after lyophilisation for 24 hours using a 
freeze drier (VirTis advantage, Biopharma Process Systems, UK). 
3.3 Polyelectrolyte complex characterisation 
3.3.1 Dynamic light scattering 
Samples of alg/pa2.5, alg/pa5 at mass ratios of 4.3:1, 3:1, 1:3, 1:4.3, and 
alg/Qpa2.5, alg/Qpa5 at ratios of 3:1 and 1:3, as well as cationic PE controls at 
equivalent concentrations were analysed for their average hydrodynamic diameter 
(Hdd), and polydispersity index (pdI) using a Nano ZS Zetasizer (Malvern 
instruments, UK). Samples were measured using plastic cuvettes, with a 




3.3.2 Transmittance studies 
As an indicator of colloidal stability, an UV-Vis spectrometer (Thermo scientific, 
UK) was used to investigate the average %Transmittance for solutions of PECs and 
equivalent PE controls at a wavelength of 570nm. A similar experiment was 
performed by Thompson et al. to provide evidence of complex formation and 
stability (2). Data was collected at time points of 0, 24, and 48 hours after PEC 
formation (n=3). 
3.3.3 Zeta potential 
Samples of alg/pa2.5 1:3 and alg/Qpa2.5 1:3, as well as pa2.5 and Qpa2.5 
(concentrations equivalent to final concentration in PECs) were analysed using a 
Nano ZS Zetasizer (Malvern instruments, UK) in folded capillary plastic cuvettes 
at 25°C (n=1).  
3.3.4 Infra-red analysis 
Sample solutions of alg/pa2.5, alg/pa5, alg/Qpa2.5, and alg/Qpa5 at ratios of 3:1 
and 1:3 were lyophilised using a freeze drier. With the resulting solid used to 
acquire a spectrum representing PECs. Data was obtained using a Thermo Nicolet 
IR spectrophotometer (Thermo Fisher Scientific, USA) with diamond tip accessory. 
Samples were measured at 32 scans per spectrum between 4000-500cm-1. 
Analysis was performed using OMNIC software. 
3.3.5 Thermal analysis 
Lyophilised samples of alg/pa2.5, alg/pa5, alg/Qpa2.5, and alg/Qpa5 (1-5mg) 
were analysed by DSC over a temperature range of 0-300°C at 20°C/minute under 
nitrogen atmosphere. The instrument was pre-calibrated with an indium standard. 
Hot-stage microscopy was used to assist in the investigation of thermal properties 
of PECs as well as ascertain any changes in thermal properties of individual 
polyelectrolytes compared to complexes. Samples of alg/pa2.5, alg/pa5, 
alg/Qpa2.5, and alg/Qpa5 were observed at 20x magnification from 20°C to 300°C 
heated at a rate of 5-10°C/minute. Images were captured using a LEICA DFC 420 
digital microscope (LEIKA, Germany) coupled to the LINKAM LTS 350 hot-stage 
(Linkam scientific instruments, UK). 
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3.3.6 Transmission electron microscopy  
Solutions of alg/pa2.5 1:3, alg/Qpa2.5 3:1 and alg/Qpa2.5 1:3 were freshly 
prepared and sent for transmission electron microscopy (TEM) at the electron 
microscopy research services facility at Newcastle University. Using a Philips 
CM100 TEM with compustage and high resolution digital image capture, a number 






















3.4 Results and Discussion 
The use of ratios of 4.3:1, 3:1, 1:3 and 1:4.3 is based on work performed on 
chitosan and alginate (1). Other ratios such as 1:1 and 2:1 were attempted but 
were found to result in immediate precipitation, perhaps due to charge 
neutralisation.     
3.4.1 Dynamic light scattering 
Dynamic light scattering (DLS), also known as photon correlation spectroscopy is 
a light scattering technique capable of producing estimates of particle size in a 
timely and non-invasive manner. Particles in suspension or solution are 
subjected to a laser, whose light is then scattered. By analysing the intensity of 
scattered light, the velocity of Brownian motion can be found. 
DLS can then be used to determine particle size by relating the diffusion 
coefficient (the Brownian motion of the measured particle in a specific 
environment) to hydrodynamic diameter according to the Stokes-Einstein 
equation (Equation 3.1) (3).                                                                          
𝐷 = 𝑘𝑇 ÷ 3𝜋𝜂𝑑 
Equation 3.1 Stokes-Einstein equation. 
Where D is the diffusion coefficient, k is the Boltzmann constant, T is the absolute 
temperature, η is the viscosity of the suspension liquid, and d is particle 
hydrodynamic diameter. 
The polydispersity of particles in solution was also measured. Polydispersity indices 
show the distribution of size data acquired by DLS, with greater values indicating 
a wider distribution of particle sizes and a lack of uniformity.  
Using this technique, a study of the different mass ratios of PEs used and the 
subsequent effect on the interaction between alginate and amphiphilic PEs towards 
the formation of PECs was carried out with regard to the average Hdd and average 
pdI. 
The amphiphilic poly (allyl amine) derivatives synthesised in chapter 2, self-
assemble into nanoaggregates at concentrations above their critical aggregation 
concentration (4). Furthermore, at the pH conditions used in PEC formation, the 
anionic carbonyl groups of sodium alginate were expected to interact 
electrostatically with the protonated and quaternary amines of amphiphilic PEs. 
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Additionally, Van der Waals forces and hydrophobic interactions were expected to 
have an effect (Figure 3.1). The combination of amphiphilic polymers based on 
poly(allyl amine) and alginate by the aforementioned forces was believed to be 
novel. 
 
Figure 3.1 Proposed electrostatic interaction between sodium alginate and 
quaternised amphiphilic poly (ally amine). The wavy bonds represent the 
hypothesised hydrophobic and Van der Waal forces between palmitic acid chains 
and alginate backbone.  
Complexes of alg/pa5 4.3:1 were analysed by DLS and compared with the results 
of a pa5 control (with a concentration equivalent to pa5 in complex). Results 
showed a reduction in Hdd and pdI for the complex compared to the pa5 alone 





Figure 3.2 Results of DLS for alg/pa5 4.3:1 and pa5 0.116mg/ml. (A) Comparison 
of average hydrodynamic diameter (B) Comparison of average polydispersity 
index. █ alg/pa5 4.3:1 █ pa5 0.116mg/ml (Mean ±SD, n=3). 





Figure 3.3 Results of DLS for alg/pa5 3:1 and pa5 0.166mg/ml. (A) Comparison 
of average hydrodynamic diameter (B) Comparison of average polydispersity 
index. █ alg/pa5 3:1 █ pa5 0.166mg/mL (Mean ±SD, n=3). 
Whereas alg/pa5 1:3 and 1:4.3 (0.5mg/mL pa5 control for both) resulted in a 





Figure 3.4 Results of DLS for alg/pa5 1:3, 1:4.3 and pa5 0.5mg/ml. (A) 
Comparison of average hydrodynamic diameter (B) Comparison of average 
polydispersity index. █ alg/pa5 1:3 █ alg/pa5 1:4.3 █ pa5 0.5mg/mL (Mean ±SD, 
n=3). 
From the figures above, it appeared that the interaction between pa5 and alginate 
led to the formation of nano-sized aggregates with reduced Hdd in all ratios 
investigated, while results seemed to be relatively stable over 48 hours. 
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It can be seen that regardless of the amount of alginate used in the experiment, 
the average Hdd of complexes was less than pa5 controls. However, the average 
pdI showed that the interaction between alginate and pa5 may have been different 
at each ratio. The average size was found to be in the range of 250-300nm for all 
pa5 complexes, but the distribution of size data was more disperse in the case of 
1:3 and 1:4.3 (0.46-0.66) in comparison to 4.3:1 and 3:1 (0.25-0.31). This may 
be due to a number of factors, including differences in electrostatic interactions, 
hydrophobic interactions, as well as the order and rate of addition of PEs in the 
formation of PECs (5, 6). 
Comparisons between complexes of pa2.5 complexes, and equivalent 
concentration pa2.5 controls produced different results to those found for pa5 





Figure 3.5 Results of DLS for alg/pa2.5 4.3:1 and pa2.5 0.116mg/mL. (A) 
Comparison of average hydrodynamic diameter (B) Comparison of average 







Figure 3.6 Results of DLS for alg/pa2.5 3:1 and pa2.5 0.166mg/mL. (A) 
Comparison of average hydrodynamic diameter (B) Comparison of average 
polydispersity index. █ alg/pa2.5 3:1 █ pa2.5 0.166mg/mL (Mean ±SD, n=3). 
In the case of alg/pa2.5 4.3:1 and 3:1 there appeared to be a relatively small 





Figure 3.7 Results of DLS for alg/pa2.5 1:3, 1:4.3 and pa2.5 0.5mg/mL. (A) 
Comparison of average hydrodynamic diameter (B) Comparison of average 
polydispersity index. █ alg/pa2.5 1:3 █ alg/pa2.5 1:4.3 █ pa2.5 0.5mg/mL (Mean 
±SD, n=3). 
Complexes of alg/pa2.5 1:3 and 1:4.3 showed a reduction in Hdd and an increase 
in pdI compared to pa2.5 alone at equivalent concentrations (figure 3.7). 
As with pa5, results for pa2.5 complexes were relatively stable over the 48 hour 
period of experimentation. 
While alg/pa2.5 1:3 and 1:4.3 presented with similar trends in changes in pdI and 
Hdd compared to their controls as their equivalent pa5 complexes, this was not 
the case for alg/pa2.5 3:1 and 4.3:1 complexes and their equivalent pa5 
complexes. It may be that the small difference in hydrophobic grafting between 
pa2.5 and pa5 had an effect on the interaction between amphiphilic PEs and 
alginate; which may be due to differences in Van der Waal forces, hydrophobic, 
and electrostatic interactions. Differences that may have arisen as a result of the 
increased number of free amines on pa2.5 compared to the more highly 
substituted, and therefore more hydrophobic, pa5. 
Figure 3.8 shows the Hdd and pdI results of pa5 complexes. 





Figure 3.8 Results of DLS for alg/pa5 4.3:1, 3:1, 1:3 and 1:4.3. (A) Comparison 
of average hydrodynamic diameter (B) Comparison of average polydispersity 




It can be seen that all complexes exhibited similar Hdd results. Whereas the 
complexes with higher concentrations of alginate (4.3:1 and 3:1), consistently 
showed smaller pdI values than complexes with higher concentrations of pa5 (1:3 
and 1:4.3). 







Figure 3.9 Results of DLS for alg/pa2.5 4.3:1, 3:1, 1:3 and 1:4.3. (A) Comparison 
of average hydrodynamic diameter (B) Comparison of average polydispersity 
index. █ alg/pa2.5 4.3:1 █ alg/pa2.5 3:1 █ alg/pa2.5 1:3 █ alg/pa2.5 1:4.3 (Mean 
±SD, n=3). 
Results for pdI appeared to be relatively similar. However, there appeared to be a 
marked difference in Hdd between the opposing ratios; with 1:3 (140nm) and 
1:4.3 (200nm) resulting in smaller average values than 4.3:1 (330nm) and 3:1 
(335nm) complexes over 48 hours. By comparing figures 3.8 and 3.9, it appeared 
that pa2.5 based complexes showed similar pdI values while Hdd showed ratio 
dependent differences. pa5 based combinations however, formed nanosized 
objects of similar average Hdd, with pdI showing ratio dependence. This may 
indicate a potential measure of control over particle size and size distribution, 
through the manipulation of alginate and PE+ concentration.   
Further investigations were then undertaken with the quaternised PEs, Qpa2.5 and 
Qpa5. The effect of quaternisation on individual amphiphilic PE self-assemblies 
with regard to Hdd and pdI can be seen in table 3.2. 
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Table 3.2 Comparison of average Hdd and pdI values of amphiphilic PEs and 
quaternised equivalents (Mean ± SD, n=3).  
 Average Hdd at 48 
hours, nm. 
Average pdI at 48 hours. 
pa5 0.166mg/mL 466.0 (59.3) 0.442 (0.049) 
Qpa5 0.166mg/mL 373.5 (34.4) 0.359 (0.051) 
pa2.5 0.166mg/mL 302.8 (17.1) 0.232 (0.019) 
Qpa2.5 0.166mg/mL 263.1 (79.6) 0.387 (0.057) 
pa5 0.5mg/mL 541.3 (54.6) 0.386 (0.057) 
Qpa5 0.5mg/mL 385.3 (19.7) 0.324 (0.031) 
pa2.5 0.5mg/mL 365.2 (29.2) 0.213 (0.011) 
Qpa2.5 0.5mg/mL 204.7 (16.3) 0.269 (0.045) 
 
With regard to Hdd, Quaternisation appeared to lead to reductions in Hdd data in 
all cases investigated. The average pdI data showed mixed results, with pa5 
0.166mg/mL and 0.5mg/mL showing reductions in average pdI following 
quaternisation, whereas pa2.5 0.166mg/mL and 0.5mg/mL showed an apparent 
increase. 
The process of quaternisation appears to have altered the state of intermolecular 
interactions for each amphiphilic PE. The presence of permanent positive charges 
on the backbone may have led to greater repulsive forces between molecules, 
leading to increased porosity of the particle structure. This in turn may have led to 
the constriction of the particle by hydrophobic attraction in order to prevent the 
penetration of the surrounding water, until a balance between repulsive and 
attractive forces was achieved. Qpa5, which has an estimated degree of 
quaternisation of 35% (Chapter 2 section 2.4.1), appeared to have a reduction in 
Hdd and pdI compared to pa5, whereas Qpa2.5, which has an estimated degree 
of quaternisation of 18%, presented with reduced average Hdd, but increased pdI. 
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The effect of quaternisation of amphiphilic poly (allyl amine) on the formation of 
PECs with alginate was investigated for Qpa5 and Qpa2.5 at ratios of 3:1 and 1:3 
only. These combinations were chosen based on the results of dynamic light 
scattering for non-quaternised PECs, as well as the increased tendency of 4.3:1 
complexes to precipitate over time.  
Figure 3.10 shows the Hdd and pdI results of quaternised complexes at a ratio of 





Figure 3.10 Results of DLS for alg/Qpa5 3:1, alg/Qpa2.5 3:1 and equivalent 
controls. (A) Comparison of average hydrodynamic diameter (B) comparison of 
average polydispersity index.     alg/Qpa5 3:1    Qpa5 0.5mg/mL    alg/Qpa2.5 
3:1     Qpa2.5 0.5mg/mL (Mean ±SD, n=3). 
From figure 3.10, it would appear that alg/Qpa5 3:1 led to reduction in Hdd 
compared to Qpa5 0.5mg/mL control, the apparent reduction in size was 
accompanied by a less clear reduction in pdI. The results for alg/Qpa2.5 3:1 and 
its control were more similar, showing perhaps that Qpa2.5 interacts with alginate 
in a different way than Qpa5, possibly due to the difference in hydrophobic 
grafting.  Both sets of data were relatively unchanged over the 48 hour 
experimentation period, indicating the formation of stable nano-aggregates with 
reduced size and size dispersity.  
Figure 3.11 shows the Hdd and pdI results of quaternised complexes at a ratio of 





Figure 3.11 Results of DLS for alg/Qpa5 1:3, alg/Qpa2.5 1:3 and equivalent 
controls. (A) Comparison of average hydrodynamic diameter (B) comparison of 
average polydispersity index.    alg/Qpa5 1:3    Qpa5 0.5mg/mL    alg/Qpa2.5 
1:3    Qpa2.5 0.5mg/mL (Mean ±SD, n=3). 
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As with the 3:1 complexes all results in figure 3.11 were relatively stable over 48 
hours. However, unlike 3:1 complexes, both alg/Qpa5 1:3 and alg/Qpa2.5 1:3 led 
to reductions in Hdd compared to their respective controls, while showing 
moderate changes in pdI. It would seem that the addition of a small amount of 
alginate led to the formation of nano-sized objects with reduced size, while the 
moderate changes in pdI indicated that the size reduction was seen in most of the 
size populations.   
Regardless of ratio used, the combination of alginate and Qpa5, or Qpa2.5 led to 
reductions in Hdd values compared to quaternised controls at equivalent 
concentrations. 
Finally, the differences between quaternised complexes and non-quaternised 
complexes were examined, with results shown in table 3.3.  
Table 3.3 Comparison of average Hdd and pdI values of non-quaternised and 
quaternised PECs at 3:1 and 1:3 ratios (Mean ± SD, n=3). 
 Average Hdd at 48 hours. Average pdI at 48 hours. 
alg/pa5 3:1 258.5 (32.6) 0.255 (0.010) 
alg/Qpa5 3:1 222.3 (15.8) 0.289 (0.008) 
alg/pa2.5 3:1 342.8 (67.4) 0.262 (0.031) 
alg/Qpa2.5 3:1 221.1 (11.1) 0.273 (0.007) 
alg/pa5 1:3 265.4 (24.1) 0.472 (0.037) 
alg/Qpa5 1:3 141.2 (6.2) 0.358 (0.045) 
alg/pa2.5 1:3 144.8 (13.4) 0.279 (0.005) 
alg/Qpa2.5 1:3 130.9 (4.9) 0.251 (0.010) 
 
It can be seen that the quaternised complexes resulted in smaller Hdd values than 
their non-quaternised counterparts regardless of ratio. The reduction in Hdd was 
attributed to increased electrostatic attraction between quaternised amphiphilic 
PEs and alginate due to the presence of quaternary nitrogen. 
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The difference in average pdI between the two types of complexes was less clear, 
with quaternised 3:1 complexes exhibiting quite similar pdI values to their non-
quaternised equivalents, which may indicate that the observed reductions in Hdd 
were uniform. Quaternised 1:3 complexes showed small reductions in pdI 
compared to non-quaternised equivalents. When viewed concomitantly with 
average Hdd data, there appeared to be a trend towards smaller, less polydisperse 
nano-sized objects. 
From the results discussed, it appears that quaternisation may lead to more 
compact nano-sized PECs than non-quaternised complexes. Furthermore, 
increasing the degree of quaternisation may lead to still greater reductions in Hdd.  
3.4.2 Transmittance studies 
The colloidal stability of prepared solutions was assessed using a UV-Vis 
spectrometer to measure sample solutions %Transmittance of light, alongside a 
visual inspection. Figure 3.12 shows the average %Transmittance of pa5 and pa2.5 





Figure 3.12 Results of %Transmittance studies for pa5 and pa 2.5 based 
complexes. (A) Comparison of average %Transmittance of alg/pa5 complexes (B) 
Comparison of average %Transmittance of alg/pa2.5 complexes. █ alg/pa5 4.3:1 
█ alg/pa5 3:1 █ alg/pa5 1:3 █ alg/pa5 1:4.3. █ alg/pa2.5 4.3:1 █ alg/pa2.5 3:1 
█ alg/pa2.5 1:3 █ alg/pa2.5 1:4.3 (Mean ±SD, n=3). 
All samples appeared to show stable results over the 48 hour monitoring period. 
For pa5 complexes, there may have been a slight trend towards increased turbidity 
when alginate was the majority component of complexes, despite the fact that 
%Transmittance values were quite similar, this is due to visual inspections showing 
that alg/pa5 4.3:1 and 3:1 began to exhibit evidence of precipitation after 24 
hours. pa2.5 based complex data showed a clearer contrast, with alg/pa2.5 4.3:1 
and 3:1 showing markedly reduced transmittance when compared to 1:3 and 
1:4.3, the visual inspections also showed that 4.3:1 and 3:1 began to precipitate 
after 24 hours, whereas 1:3 and 1:4.3 remained unchanged over 48 hours. 
Increasing the concentration of alginate in PECs appeared to lead to increased 
turbidity of solutions and subsequently reduced transmittance of light; this was 
most clearly seen in 3:1 complexes. 
Tables 3.4 and 3.5 show the %Transmittance of PE+ complexes with alginate 
compared to equivalent PE+ controls.  
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Table 3.4 Comparison of average %Transmittance of alg/pa5 complexes and 
equivalent pa5 controls at 48 hours after preparation (Mean ± SD, n=3). 
Sample Average %Transmittance 
at 48 hours, % 
alg/pa5 4.3:1 73.4 (0.8) 
pa5 0.116mg/mL  84.2 (0.6) 
alg/pa5 3:1 64.8 (2.5) 
pa5 0.166mg/mL  84.7 (1.1) 
alg/pa5 1:3 73.7 (2.4) 
alg/pa5 1:4.3 79.0 (0.9) 
pa5 0.5mg/mL  76.6 (0.5) 
 
Table 3.5 Comparison of average %Transmittance of alg/pa2.5 complexes and 
equivalent pa2.5 controls at 48 hours after preparation (Mean ± SD, n=3). 
Sample Average %Transmittance 
at 48 hours, % 
alg/pa2.5 4.3:1 66.7 (2.1) 
pa2.5 0.116mg/mL 86.2 (0.6) 
alg/pa2.5 3:1 58.6 (5.4) 
pa2.5 0.166mg/mL 86.1 (0.5) 
alg/pa2.5 1:3 82.4 (1.6) 
alg/pa2.5 1:4.3 82.4 (2.4) 




Controls exhibited greater transmittance of light than complexes in general, except 
for alg/pa5 1:4.3, which resulted in solutions with greater average 
%Transmittance than its 0.5mg/mL pa5 controls.  
%Transmittance data for all quaternised complexes at ratios of 3:1 and 1:3 can 
be seen in figure 3.13. 
 
Figure 3.13 Results of %Transmittance studies for quaternised complexes. █ 
alg/Qpa5 3:1 █ alg/Qpa2.5 3:1 █ alg/Qpa5 1:3 █ alg/Qpa2.5 1:3 (Mean ±SD, 
n=3). 
In all cases quaternised complexes clearly led to increased %Transmittance when 
compared to equivalent non-quaternised PECs seen in figure 3.12, which was 
perhaps due to the increased interaction with alginate, and reduced incidence of 
precipitation. As with previous results, the %Transmittance data of all quaternised 
complexes remained stable over 48 hours. 







Table 3.6 Comparison of the average %Transmittance of alg/QPE+ complexes and 
their equivalent PE+ controls at 48 hours after sample preparation (Mean± SD, 
n=3). 
Sample Average %Transmittance 
at 48 hours, % 
alg/Qpa5 3:1 76.3 (2.0) 
Qpa5 0.166mg/mL 86.9 (0.0) 
alg/Qpa2.5 3:1 75.9 (2.2) 
Qpa2.5 0.166mg/mL 87.0 (0.2) 
alg/Qpa5 1:3 81.4 (1.6) 
Qpa5 0.5mg/mL 85.1 (0.2) 
alg/Qpa2.5 1:3 84.6 (0.4) 
Qpa2.5 0.5mg/mL 86.2 (0.8) 
 
As with non-quaternised complexes, PE+ controls showed greater %Transmittance 
values than equivalent complexes, which was to be expected due to the absence 
of alginate and the good solubility of quaternised PEs. 
When %Transmittance data is viewed concomitantly with Hdd and pdI data, it may 
indicate the formation of nanosized objects of stable size, size dispersity, and 
colloidal stability over at least 48 hours.    
3.4.3 Zeta potential 
Zeta potential is the measure of the electrical potential at the shear plane between 
the diffuse ions of the solvent and the condensed ions surrounding the charged 
surface of particles. Measurement of zeta potential has long been used as an 
indicator of colloidal stability. Zeta potential values indicating good stability are 
usually greater than 30mV whether positive or negative, values greater than 60mV 
are often seen as possessing excellent colloidal stability (7, 8).   
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Results of zeta potential measurements can be seen in table 3.7. Analysis was 
performed using solutions of pH 4.6 and 8.0, so as to mimic the conditions used 
in experiments discussed in chapters 3 and 4, respectively. 
Table 3.7 Results of Zeta potential studies of pa2.5, Qpa2.5, alg/pa2.5 1:3 and 
alg/Qpa2.5 1:3 (n=1). 
Sample pH 4.6  pH 8.0  
pa2.5 69.9  63.2  
Qpa2.5 60.7  49.3  
alg/pa2.5 1:3 63.7  50.2  
alg/Qpa2.5 1:3 59.3  54.0  
 
Cationic PEs pa2.5 and Qpa2.5 showed greater positive values at the more acidic 
pH, Qpa2.5 surprisingly was found to have a lesser positive charge than pa2.5 
regardless of pH. Samples of pa2.5 and Qpa2.5 showed increased positive values 
at pH 4.6, which was to be expected as ionisation of amines would be greater in 
an acidic environment. 
The complexes investigated for zeta potential contained low concentrations of 
sodium alginate and accordingly resulted in elevated positive charges, even at pH 
8. 
The results of Zeta potential, when discussed in conjunction with DLS, and 
%Transmittance studies, support the formation of stable colloidal particles in the 
nano-size range. 
3.4.4 Infra-red analysis 
Analysis and comparison of the IR spectra of individual PEs with those of PECs, 
was used to investigate the anticipated interaction between alginate and 
amphiphilic PEs. Analysis of individual PEs can be found in chapter 2 (section 
2.4.2). 
As shown in figure 3.14, sodium alginate exhibits O-H stretching vibrations at 
3279cm-1. Carboxylic acid carbonyl shows antisymmetric and symmetric stretching 
99 
 
vibrations at 1596cm-1 and 1406cm-1 respectively. The signal from 1026-1080 
represents the antisymmetric stretch of C-O-C bonds (9). 
 
Figure 3.14 IR spectra of sodium alginate and pa2.5 based complexes at 3:1 and 
1:3 mass ratios. 
Upon investigation of the alg/pa2.5 3:1 combination, alginate was quite clearly the 
majority given the similarity in spectra to alginate alone. Weak C-H stretch 
vibrations at 2923cm-1 were the only indication of the presence of pa2.5. While a 
reduction in transmittance at 3357cm-1 may be due to an increase in hydrogen 
bonding in the system, a similar result was found by Fang et al. who synthesised 
a PEC from poly(L-glutamic acid) and chitosan (10). Furthermore a new signal at 
1520cm-1 was detected, which may be associated with the protonated amines of 
pa2.5 and an interaction with alginate. 
The 1:3 combination of alg/pa2.5 presented a result more representative of pa2.5. 
Despite alginate being in the minority, C-O-C stretch vibrations at 1032-1078cm-1 
were clearly visible, as well as carbonyl stretching vibrations at 1608cm-1 and 
1407cm-1. pa2.5 contributed to the spectrum with C-H stretching and bending 











































































































































































































































































vibrations at 1175cm-1. As with the 3:1 ratio, the vibration at 3373cm-1 showed 
reduced transmittance when compared to PEs alone. 
The signal at 1513cm-1 is absent from the spectra of alginate and pa2.5, and may 
be a similar indication of some interaction as with the new signal found at 1520cm-
1 in alg/pa2.5 3:1. 
Complexes based on pa5 (Figure 3.15) showed quite similar results to those of 
pa2.5. 
 
Figure 3.15 IR spectra of sodium alginate and pa5 based complexes at 3:1 and 
1:3 mass ratios. 
In the case of alg/pa5 3:1 complex, characteristic vibrations of alginate were 
visibly dominant, while pa5 provided C-H stretching vibrations at 2919cm-1 and 
2850cm-1. A small shoulder at 1520cm-1 may be similar to the new signals detected 
in pa2.5 complexes. The strong, broad peak at 3356cm-1 may be due to stretching 
vibrations of O-H (present in alginate) and N-H (present in pa5). 
The reduction in transmittance in the region from 3200-3400cm-1 of the PECs was 
attributed to hydrogen bonding. It could simply be evidence of the presence of 

















































































































































































































































































The alg/pa5 1:3 complex showed the distinctive peaks of alginate at 1613cm-1, 
1410cm-1, and 1031cm-1. Vibrations attributed to pa5 included C-H stretching at 
2917cm-1 and 2849cm-1, with bending vibrations at 1465cm-1. C-N stretching 
vibrations were visible at 1175cm-1. A new signal was detected at 1515cm-1 in a 
similar result to previously mentioned complexes. 
The new signals detected ≈1515cm-1 may be the result of electrostatic interaction 
between PEs. Furthermore there appears to be a slight 5-10cm-1 shift in carbonyl 
vibration frequency of alginate, which may also indicate an interaction. Li et al. 
attributed similar shifts in the frequency of carbonyl groups of alginate and amine 
groups of chitosan to electrostatic interaction, in a study of PEC formation (11). 
The IR spectra of Qpa2.5 and its complexes with alginate can be seen in figure 
3.16; an IR analysis of Qpa2.5 was discussed in chapter 2. The alg/Qpa2.5 3:1 
based complex showed some of the characteristic vibrations of sodium alginate at 
1600cm-1, 1411cm-1 and 1028-1080cm-1. Vibrations indicative of Qpa2.5 were less 
obvious. C-H stretching vibrations can be seen at 2924cm-1. A small peak at 
1721cm-1 was not present in either of the original PEs, and may be previously 
undetected carbonyl stretch vibrations. There appears to be a slight shoulder at 
1514cm-1 which may be similar to the signal at 1518cm-1 found in Qpa2.5 which 
was attributed to Quaternary nitrogen in chapter 2. The shift from 1518cm-1 to 
1514cm-1 may indicate some form of interaction, as in the case of the new signals 
found in non-quaternised complexes. 
The use of IR as evidence of electrostatic interaction between PEs has been used 




Figure 3.16 IR spectra of sodium alginate and Qpa2.5 based complexes at 3:1 
and 1:3 mass ratios. 
The alg/Qpa2.5 1:3 complex shows similarities to the 3:1 complex with regard to 
alginate vibrations. Furthermore, as in the case of alg/pa2.5 and alg/pa5, the 1:3 
complex exhibits more signature vibrations of the cationic component, such as a 
sharper signals at 2919cm-1, 1609cm-1 and 1466cm-1. 
The vibrations at 1519cm-1 and 1412cm-1 were attributed to the electrostatic 
interaction of PEs in a result similar to those of previously discussed complexes. 
The IR spectra of Qpa5 based complexes with alginate are shown in figure 3.17. 
At a mass ratio of 3:1 the spectrum of alg/Qpa5 is quite similar to that of sodium 
alginate, with carbonyl stretch vibrations at 1598cm-1 and 1411cm-1, a weaker 
signal at 1717cm-1 was detected, despite being absent from alginate and Qpa5. 
The vibrations at 1027-1083cm-1 were similarly typical of the anionic PE. Although 
not detected by the software, there may be a weak signal at approximately 
1520cm-1 (denoted by an arrow in figure 3.17), which could be associated with the 

















































































































































































































































































































Figure 3.17 IR spectra of sodium alginate and Qpa5 based complexes at 3:1 and 
1:3. 
As for alg/Qpa5 1:3, the spectrum showed the C-H stretching and bending 
vibrations of Qpa5 at 2918cm-1, 2849cm-1 and 1466cm-1 respectively. Results 
also showed a signal at 959cm-1 which appeared to be similar to the signal at 
960cm-1 found in Qpa5, which was attributed to quaternary ammonium during 
the discussion of Quaternised PEs in chapter 2. 
The alg/Qpa5 1:3 combination also showed some of the characteristic vibrations 
of alginate at 1030-1083cm-1. 
The signals at 1525cm-1 and 1413cm-1 may have been related to the vibrations 
at 1518cm-1 in Qpa5 and 1406cm-1 in alginate. The shift in wave number might 
have been caused by some form of interaction between the two PEs, in a result 




















































































































































































































































3.4.5 Thermal analysis 
The thermal properties of sodium alginate were investigated using DSC and hot-
stage microscopy. Results of DSC analysis are shown in figure 3.18. 
 
Figure 3.18 DSC thermograms of alginate, pa2.5, alg/pa2.5 3:1 and alg/pa2.5 
1:3. 
Alginate showed a wide exotherm at 249°C which was attributed to decomposition, 
similar results were found by Soares et al. in a study of the thermal properties of 
alginate (13). 
Hot-stage microscopy images of alginate (figure 3.19) showed that discolouration 
of the sample began at approximately 190°C, followed by contraction starting from 
230°C up to 260°C; this is in agreement with results of DSC which showed a peak 
decomposition temperature of 249°C. Upon cooling to room temperature the 




Figure 3.19 Hot-stage images of sodium alginate at magnification x20. (A) Room 
temperature (B) 200°C (C) 230°C (D) 300° (E) Cooled to room temperature. 
The thermogram of alg/pa2.5 3:1 complex (figure 3.18) is distinctly different from 
the thermogram of pa2.5 and sodium alginate, despite alginate being the major 
component of the complex. Results showed an endotherm at 230°C, which may 
be an indicator of decomposition. 
Images from hot stage-microscopy (figure 3.20) show that discolouration of the 
sample began at approximately 170°C which did not show any correlation to DSC 
data. Furthermore, onset of discolouration at 170°C was found to be less than that 
found for pa2.5 (210°C) and alginate (190°C). There was also no evidence of 




Figure 3.20 Hot-stage images of alg/pa2.5 3:1 complex at magnification x20. (A) 
Room temperature (B) 100°C (C) 170°C (D) 200°C (E) 300°C (F) Cooled to room 
temperature. 
The DSC thermogram of alg/pa2.5 1:3 complex (figure 3.18) showed no obvious 
thermal events; whereas, hot-stage images (figure 3.21) showed that the complex 
began to discolour at 180°C continuing up to 300°C. Upon cooling, the sample did 
not return to its preheated state, indicating degradation of some or all of the 
complex components. 






Figure 3.21 Hot-stage images of alg/pa2.5 1:3 complex at magnification x20. (A) 
Room temperature (B) 100°C (C) 190°C (D) 210°C (E) 300°C (F) Cooled to room 
temperature. 
The major component in the complex was pa2.5, which when investigated in 
chapter 2 (Section 2.4.3, Figure 12) clearly underwent a melting process at 140°C, 
however when in complex with alginate there appeared to be no evidence of 
melting on DSC and hot-stage data. It would appear that the melting point of the 
complex was increased to a point above decomposition temperature, which was 
assumed to have taken place upon discolouration. 




Figure 3.22 DSC thermogram of sodium alginate, pa5, alg/pa5 3:1 and alg/pa5 
1:3 (A) sodium alginate and pa5 (B) pa5 based complexes. 
According to the DSC thermogram of alg/pa5 3:1 complex (figure 3.22), the 
complex does not exhibit the same thermal events as either pa5 or alginate alone, 
it would appear that the resultant complex led to changes in one or both of the 
constituent PEs. As alginate is the chief component in alg/pa5 3:1, it would be 
expected to exhibit an exotherm at 249°C, this was however absent, as the only 
thermal event detected was an indistinct signal at 187°C. 
Meanwhile hot-stage images of alg/pa5 3:1 complex (figure 3.23), showed 
discolouration beginning at 185°C which is similar to alginate alone. Therefore it 























































Figure 3.23 Hot-stage images of alg/pa5 3:1 complex at magnification x20. (A) 
Room temperature (B) 105°C (C) 185°C (D) 225°C (E) 285°C (F) cooled to room 
temperature.  
There appears to be differences between alg/pa5 3:1 and alg/pa2.5 3:1, which as 
discussed above, resulted in a reduced temperature of onset of discolouration. The 
difference in hydrophobic grafting between pa2.5 and pa5 may have some role in 
the observed disparity. 
DSC investigation of alg/pa5 1:3 (figure 3.22) complex showed a possible thermal 
event at 184°C. It may be that the DSC device used in this study did not possess 
the sensitivity to detect a similar endotherm for alg/pa2.5 1:3, indicating that 
these thermograms may be associated with the small difference in hydrophobic 
substitution.  
Hot stage images (figure 3.24) showed discolouration of the sample beginning at 
170°C, becoming more obvious by 220°C and continuing up to 300°C. There was 
no evidence of melting, which would be expected around 146°C for a complex with 
a high concentration of pa5. Furthermore, the process was irreversible and the 
sample did not revert to original state on cooling. 
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As with alg/pa2.5 1:3, there appeared to be a reduction in the temperature of 
onset of discolouration (assumed to be decomposition), coupled with a change 
melting properties. 
 
Figure 3.24 Hot-stage images of alg/pa5 1:3 complex at magnification x20. (A) 
Room temperature (B) 100°C (C) 190°C (D) 240°C (E) 300°C (F) cooled to room 
temperature. 
It appeared that the electrostatic interaction produced a reduction in 
decomposition temperature, Fang et al found an opposite result using poly(L-
glutamic acid) and chitosan to produce PEC microspheres; which showed increased 
decomposition temperatures compared to individual components (10). 
DSC investigations of complexes based on the interaction between Qpa2.5 and 




Figure 3.25 DSC thermograms of alginate, Qpa2.5, alg/Qpa2.5 3:1 and 
alg/Qpa2.5 1:3. 
The thermogram of alg/Qpa2.5 3:1 complex showed an endotherm at 225°C, 
which is distinctly different from individual PEs. 
Hot-stage images can be seen in figure 3.26, and showed discolouration of the 
sample beginning at 195°C, as well as an apparent contraction of the sample. The 
result appears to indicate the decomposition of the sample in a manner reminiscent 
of sodium alginate, albeit with an earlier onset of sample contraction, 195°C 



















































Figure 3.26 Hot-stage images of alg/Qpa2.5 3:1 complex at magnification x20. 
(A) Room temperature (B) 100°C (C) 170°C (D) 205°C (E) 280°C (F) cooled to 
room temperature. 
DSC results of alg/Qpa2.5 1:3 showed an endotherm at 222°C, which is absent 
from the thermograms of individual PEs. 
Hot-stage images (figure 3.27) showed discolouration of the sample beginning at 
200°C and continuing to 270°C. Individual samples of Qpa2.5 did not exhibit 
discolouration until 255°C. Therefore, it would appear that complexation led to a 
reduction in what was assumed to be the decomposition temperature of the major 





Figure 3.27 Hot-stage images of alg/Qpa2.5 1:3 complex at magnification x20. 
(A) Room temperature (B) 100°C (C) 200°C (D) 240°C (E) 280°C (F) cooled to 
room temperature. 
Results of DSC for Qpa5 based complexes are shown in figure 3.28.  
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DSC results of alg/Qpa5 3:1 complex showed a thermal event at 224°C, which is 
distinct from Qpa5 and alginate. The result showed some similarity to that of 
alg/Qpa2.5 3:1. 
Hot stage images (figure 3.29) showed discolouration and contraction beginning 
at approximately 200°C and continuing to 290°C, which was slightly higher than 
alginate (190°C). There was no change on cooling to room temperature with 
discolouration attributed to decomposition. 
 
 
Figure 3.29 Hot-stage images of alg/Qpa5 3:1 complex at magnification x20. (A) 
Room temperature (B) 100°C (C) 180°C (D) 240°C (E) 290°C. 
The DSC results of alg/Qpa5 1:3 complex (figure 3.28), showed an endotherm at 
212°C, which was again different from either component. While hot-stage images 
(figure 3.30) showed discolouration and contraction beginning at 185°C continuing 
up to 290°C. Qpa5 alone did not show signs of discolouration until 240°C, 
indicating a possible reduction in temperature of decomposition in a result similar 




Figure 3.30 Hot-stage images of alg/Qpa5 1:3 complex at magnification x20. (A) 
Room temperature (B) 100°C (C) 170°C (D) 240°C (E) 290°C (F) cooled to room 
temperature. 
It would appear that the electrostatic interaction between PEs led to the formation 
of complexes which had different thermal properties than the component PEs 
alone. In the case of pa2.5, the pair of endotherms discussed in chapter 2 were 
consistently absent from thermograms of complexes. Furthermore, there was no 
observable evidence of melting for alg/pa2.5 1:3 even though pa2.5 was in the 
majority. Additionally, the endotherm and exotherm pairing of pa5 was absent 
from alg/pa5 complexes, as was any sign of melting. Qpa5 and Qpa2.5 based 
complexes, which lacked clear individual thermal signs showed a reduction in 
apparent decomposition temperature, similarly to non-quaternised complexes. The 
reduction in decomposition temperature appeared to be clearest in 1:3 complexes 
regardless of quaternisation, indicating that a small amount of alginate may exert 
more of an effect on the thermal properties of amphiphilic PEs, than the reverse 
case of 3:1 complexes. 
3.4.6 Transmission electron microscopy 
Only a select number of samples were sent for TEM analysis due to cost. Therefore 
alg/pa2.5 1:3, alg/Qpa2.5 3:1, and alg/Qpa2.5 1:3 were chosen based on the 
stability and size data acquired from DLS, %Transmittance and Zeta potential. Due 
116 
 
to difficulties that arose at the time of preparation, it was not possible to include 
alg/pa2.5 3:1 to the list of analysed samples. 
Figure 3.31 shows the results for alg/pa2.5 1:3. 
 
Figure 3.31 TEM images for alg/pa2.5 1:3. (A) 450000x (Bar=20 nm) (B) 
245000x (Bar=100 nm) (C) 245000x (Bar =100 nm). 
As shown in figure 3.31, alg/pa2.5 1:3 appeared to result in a mixture of spherical, 
rod shaped, and agglomerated spherical nanoparticles.  
Figure 3.32 shows a sample of the TEM results of alg/Qpa2.5 3:1. 
 
Figure 3.32 TEM images for alg/Qpa2.5 3:1. (A) 180000x (Bar= 100 nm) (B) 
130000x (Bar= 100 nm). 
Results appeared to show the formation of individual spherical nanoparticles and 
large agglomerates which may contain spherical and needle shaped structures. 
Figure 3.33 shows some of the TEM results of alg/Qpa2.5 1:3. 





Figure 3.33 TEM images for alg/Qpa2.5 1:3. (A) 450000x (Bar= 20 nm) (B) 
130000x (Bar= 100 nm). 
The TEM results for alg/Qpa2.5 1:3 indicated the formation of spherical, rod, and 
needle shaped nanoparticles and were similar to those of alg/Qpa2.5 3:1 (Figure 
3.32). 
From figures 3.31-3.33, it can be seen that the complexes investigated result in a 
mixture of different particle morphologies and sizes. The presence of agglomerates 
in quaternised complex samples may indicate precipitation. However, this was not 
evident from transmittance or DLS data or visual inspection, and all TEM samples 
were analysed within 48hr of preparation. Further investigations would be required 
to ascertain what has caused this apparent agglomeration and if it is possible to 
separate the individual particles which appeared to be trapped inside this 
agglomerated structure. Palmitoyl grafted poly (allyl amine) has been shown to 
form nanoparticles in the literature, Thompson et al. synthesised a 5% palmitoyl 
grafted poly (allyl amine), which appeared to form discrete nanoparticles with a 
size range of 80-150nm and was in relatively close agreement with the group’s 
DLS data (4). It was not clear if the smaller individual particles were complexes of 
alginate and PE+ or self-assemblies of PE+.   
There was quite a discrepancy in size data between DLS and TEM in this 
experiment, with average Hdd results falling within the range of 150-350nm, while 
results from TEM showed particles with diameters of much greater range 
(approximately 25-100nm for discrete particles to several hundred nanometers in 
the case of agglomerates). This may be due to the dehydration of samples during 
preparation for electron microscopy which has been found with other polymer 





The electrostatic interaction between amphiphilic PEs (quaternised and non-
quaternised) and sodium alginate can lead to the formation of nano-sized PECs in 
the region of 130-400nm. Data from transmittance studies showed some 
agreement with DLS data. 
IR spectroscopy results may have shown some evidence of electrostatic interaction 
between PEs, with small shifts in the vibrational frequencies of charge carrying 
sections of PEs, perhaps indicating changes in bond strength.    
By investigating the thermal properties of lyophilised samples of PECs and 
comparing the results with those of individual PEs, it appeared that the 
electrostatic interaction led to marked changes in the behaviour of samples under 
investigation, including a change in melting and decomposition temperatures. 
Finally, TEM images appear to show PECs resulting in a number of possible 
conformations including spherical, rod, and needle shaped particles. Whether the 
aforementioned morphologies are the same in the hydrated state is not known. 
Following these findings, a number of the synthesised PECs will be investigated 
towards further complexation with insulin, discussed in chapter 4. 
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4. Polyelectrolyte interaction with Insulin 
Following on from the synthesis of PECs in chapter 3, subsequent work involved 
the formulation of insulin with selected PECs. Insulin was to be initially mixed with 
one of the available cationic polyelectrolytes (PE+) before the addition of sodium 
alginate to result in a final alg/PE+/insulin polyelectrolyte complex (PEC). The PE+ 
used were either pa2.5 or Qpa2.5 as they were found to form stable PECs (details 
in chapter 3). 
Techniques used in the characterisation of results were similar to those used in 
chapter 3, and included dynamic light scattering (DLS), infra-red analysis, 
differential scanning calorimetry (DSC) and hot stage microscopy. Zeta potential 
and %Transmittance were also used with DLS to achieve a better understanding 
of the effect of complexation between insulin and the polymers on PEC stability.  
The ability of PECs, synthesised from alginate and hydrophobically grafted poly 
(allyl amine), to protect incorporated insulin from enzymatic degradation by α-















Recombinant human insulin (Sigma Aldrich), α-chymotrypsin (type II from bovine 
pancreas, ≥40 units/mg protein) (Sigma Aldrich), acetonitrile (HPLC grade) (Fisher 
Scientific, UK), trifluoroacetic acid (HPLC grade) (Fisher Scientific, UK). 
Polyelectrolytes used in the synthesis of PECs included sodium alginate (Mw= 
120000-190000Da) (Sigma Aldrich, UK), and previously synthesised PE+ pa2.5, 
and Qpa2.5. 
4.2 Insulin polyelectrolyte complex formation 
Formation of PECs with insulin was based on the work of Thompson et al. (1). 
Solutions of alg/PE+ 1:3 (where PE+ is either pa2.5 or Qpa2.5) with insulin were 
to be prepared at a mass ratio of 2:1 in a stock of distilled water buffered to a pH 
of ≈8 with 1M hydrochloric acid and 1M sodium hydroxide, henceforth known as 
solvent. 
Insulin (3.3mg) was dissolved in 2.5mL 0.01M hydrochloric acid solution, and PE+ 
(5mg) was sonicated in 2.5mL pH 8 solvent, in separate small vials. The PE+ 
solution was poured by hand into the insulin solution and the pH was adjusted to 
8 using 1M hydrochloric acid and/or 1M sodium hydroxide. 
Alginate (1.6mg) was dissolved in 5mL pH 8 solvent, and was then added drop-
wise to PE+/insulin solution from a burette over 5 minutes under gentle magnetic 
stirring (n=3). 
Using similar polymer mass ratios, solutions of alg/PE+/insulin were prepared at 
pH 4.6 (for use in Zeta potential; section 4.3.3) using distilled water rather than 
pH 8 solvent. The final solutions were adjusted to pH 4.6 using 1M hydrochloric 







4.3 Insulin polyelectrolyte complex characterisation 
Characterisation of PEC results was performed in both the liquid state following 
sample preparation, and in the solid state, following lyophilisation for 24 hours 
using a freeze drier (VirTis advantage, Biopharma Process Systems, UK). 
4.3.1 Dynamic light scattering 
Hdd and pdI were determined for samples of alg/pa2.5 and alg/Qpa2.5 (1:3), and 
alg/pa2.5/insulin and alg/Qpa2.5/insulin. Approximately 1mL of sample was added 
to disposable plastic cuvettes, which were then analysed using a Nano ZS Zetasizer 
(Malvern instruments, UK) at a temperature of 25°C. Measurements were taken 
at time points of 0.25, 0.5, 1, 2, 24, and 48 hours after complexation (n=3).  
4.3.2 Transmittance studies 
Stability of colloidal solutions of alg/pa2.5 and alg/Qpa2.5 (1:3), and 
alg/pa2.5/insulin and alg/Qpa2.5/insulin were assessed using an UV/Vis 
spectrometer (Thermo scientific, UK). Using plastic cuvettes, the %transmittance 
of samples were analysed at a wavelength of 570nm. Measurements were taken 
immediately after sample preparation (t = 0 hours), as well as after 24 and 48 
hours (n=3).  
4.3.3 Zeta potential  
Samples of alg/pa2.5/insulin, alg/Qpa2.5/insulin and insulin alone were analysed 
at pH 4.6 and 8 using a Nano ZS Zetasizer (Malvern instruments, UK) in folded 
capillary plastic cuvettes at 25°C (n=1). 
4.3.4 Thermal analysis 
Solutions of insulin, alg/pa2.5/insulin and alg/Qpa2.5/insulin were lyophilised and 
investigated using differential scanning calorimetry, where 1-5mg samples were 
run from 0-300°C at a rate of 20°C/minute under nitrogen environment (n=1). 
The instrument was pre-calibrated with an indium standard. 
Hot-stage microscopy was also used in the investigation of thermal properties of 
the same lyophilised samples. Samples were observed at x20 magnification from 
20°C to 300°C heated at a rate of 5-10°C/minute. Images were captured using a 
LEICA DFC 420 digital microscope (LEIKA, Germany) coupled to the LINKAM LTS 
350 hot-stage (Linkam scientific instruments, UK). 
124 
 
4.3.5 Infra-red analysis 
Lyophilised samples of alg/pa2.5/insulin and alg/Qpa2.5/insulin were analysed 
using a Thermo Nicolet IR spectrophotometer (Thermo Fisher Scientific, USA) with 
diamond tip accessory after an initial background scan. Samples and background 
were measured at 32 scans per spectrum between 4000-500cm-1, and analysed 
using accompanying OMNIC software. 
4.3.6 Determination of insulin complexation 
Insulin standard calibration curve was prepared using dilutions (0.05, 0.1, 0.5, 
0.75, 1.0mg/mL) of insulin. Samples were analysed by HPLC using a Perkin Elmer 
Series 200EP diode array detector (λMax=276nm), a series 200 pump, with a series 
225 autosampler (injection volume= 100μL) (n=3). The stationary phase was a 
BEH 130 C18 column (4.6mm × 150mm; 151 Ǻ) (Waters Corporation, USA), the 
mobile phase consisted of 0.3% TFA buffered distilled water and 0.3% TFA 
buffered acetonitrile using a gradient system whereby water:acetonitrile 75:25 
was gradually changed to 50:50 over 10 minutes at a flow rate of 1mL/min, 
followed by column re-equilibration at 75:25 for 5 minutes. The mean area under 
the insulin peak was used to plot a calibration graph of area against insulin 
concentration, accompanying data included the coefficient of determination, and 
the limits of detection and quantification. 
Insulin loaded complexes and insulin stock solutions were subsequently analysed 
for insulin concentration using the above method (n=3). 
Insulin loading was estimated using HPLC data (equation 4.1). 
𝐶𝑜𝑚𝑝𝑙𝑒𝑥𝑎𝑡𝑖𝑜𝑛 𝑒𝑓𝑓𝑖𝑐𝑖𝑒𝑛𝑐𝑦 = (
𝐷𝑒𝑡𝑒𝑐𝑡𝑒𝑑 𝑐𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑖𝑛𝑠𝑢𝑙𝑖𝑛 𝑖𝑛 𝑃𝐸𝐶
𝐶𝑜𝑛𝑐𝑒𝑛𝑡𝑟𝑎𝑡𝑖𝑜𝑛 𝑜𝑓 𝑖𝑛𝑠𝑢𝑙𝑖𝑛 𝑠𝑡𝑜𝑐𝑘 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
) × 100 
Equation 4.1 Estimation of the complexation efficiency of insulin in final 
polyelectrolyte complex formulation.    
4.3.7 α-Chymotrypsin enzyme study 
The ability of insulin incorporated PECs to resist enzymatic degradation of α-
chymotrypsin was investigated using samples of alg/pa2.5/insulin and 
alg/Qpa2.5/insulin and an insulin only control. 
Solutions of α-chymotrypsin (2mL; 5mg/mL) and insulin PEC solution 
alg/PE+/insulin at a polymer to insulin ratio of 2:1 (4.5mL; PE+ 0.5mg/mL, alginate 
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0.16mg/mL, insulin 0.33mg/mL) were prepared at pH 8 on the day of 
experimentation. Both solutions were incubated for 1 hour at 37°C using a water 
bath. Following this, α-chymotrypsin (0.05ml; 5mg/mL) was added to the insulin 
PEC solution. Aliquots of the enzyme-PEC solution (0.2ml) were withdrawn every 
15 minutes for 2 hours and added to ice cold TFA solutions (0.015mL, 0.1% (v/v)) 
in order to halt all enzymatic activity at the point of withdrawal (n=3). 
4.3.8 Transmission electron microscopy 
Solutions of alg/pa2.5/insulin, alg/Qpa2.5/insulin were freshly prepared and sent 
for transmission electron microscopy (TEM) at the electron microscopy research 
services facility at Newcastle University. Using a Philips CM100 TEM with 
compustage and high resolution digital image capture, a number of images were 



















4.4 Results and discussion 
4.4.1 Dynamic light scattering 
The results of DLS for alg/PE+/Insulin can be seen in figure 4.1. The effect of the 
addition of insulin to PEC formation appeared to have led to some changes in size 
data. In the case of alg/pa2.5/Insulin there appeared to be little change with 
regard to Hdd. However, the complexation of insulin with the quaternised PEC 
appeared to lead to an increase in Hdd values. 
The change in Hdd, or lack thereof, could be due to the way insulin interacts with 
the other components of the PEC. For alg/pa2.5/insulin, it may be that insulin 
predominantly interacts with the hydrophobic core of the PEC and so results in 
similar or slightly more compact complexes. The interaction of insulin with Qpa2.5 
may have involved complexation with the charged surface of the polymer due to 
the presence of quaternary nitrogen. This could have led to insulin coating the 
outer layer of the polymer, causing a thicker corona to form and so increasing Hdd 
values. Thompson et al. prepared complexes of a similar amphiphilic poly (allyl 
amine) with insulin; a quaternised derivative was also used in combination with 
insulin. In both cases they found that the addition of insulin led to the formation 
of nano-sized complexes with reduced Hdd and pdI compared to solutions of 
amphiphilic polymer (or the quaternised derivative) alone (1). The introduction of 
sodium alginate in this work and the subsequent change in electrostatic 
interactions e.g. the competition between insulin and alginate for the positive 
charge on PE+, may be responsible for the difference in DLS data compared to the 
work of Thompson et al.   Hydrodynamic size data appeared to be relatively stable 
over 48 hours for all complexes suggesting these formulations were stable over 





Figure 4.1 Results of DLS for insulin PECs and controls. (A) Comparison of 
average hydrodynamic diameter (B) Comparison of average polydispersity index.     
alg/pa2.5/Insulin█ alg/pa2.5 control    alg/Qpa2.5/Insulin █alg/Qpa2.5 control 
(Mean ±SD, n=3). 
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Figure 4.1-B shows the average polydispersity indices over 48 hours. It can be 
seen that there appeared to be a trend towards a reduction in pdI, which may 
indicate that the insulin incorporated PECs may lead to the formation of nano-sized 
aggregates with increased uniformity of size distributions. 
4.4.2 Transmittance studies 
Figure 4.2 shows the results of transmittance studies for non-quaternised and 
quaternised PECs with insulin.  
 
Figure 4.2 Results of %Transmittance studies for insulin PECs and controls. 
alg/pa2.5/insulin █ alg/pa2.5 control    alg/Qpa2.5/Insulin █ alg/Qpa2.5 control 
(Mean ±SD, n=3). 
The %Transmittance values of insulin PEC sample solutions showed a reduction in 
transmittance of light for non-quaternised and quaternised samples. 
On visual inspection insulin PECs were translucent whereas controls were quite 
clear. This may indicate a degree of particle aggregation in the system, leading to 
the reduction in light transmittance. Despite the increase in turbidity all 
transmittance data appeared to remain stable over 48 hours, and there were no 
obvious signs of precipitation. Coupled with DLS data, it would appear that the 
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introduction of insulin did not hinder the formation of stable colloidal nano-sized 
aggregates.   
4.4.3 Zeta potential 
According to Langkjær et al. the isoelectric point of human insulin is at pH 5.4, 
above which it is negatively charged and below which it is positively charged (2). 
At pH 8, insulin and alginate would be expected to be deprotonated and carry 
negative charges, while pa2.5 and to a lesser degree Qpa2.5, would be expected 
to show a reduction in positive charge (Section 3.4.3 table 3.7). 
PECs with insulin were prepared at pH 4.6 and 8, which were the conditions used 
in PEC preparation in chapter 3 and enzymatic studies, respectively. Results of 
Zeta potential are shown in table 4.1. 
Table 4.1 Results of Zeta potential for insulin, alg/pa2.5/insulin, and 
alg/Qpa2.5/insulin (n = 1); [Zeta potential of PEC control]. 
 pH 4.6 pH 8.0 
Insulin control 26.4  -14.1 
alg/pa2.5/insulin 56.5 [63.7] 49.2 [50.2] 
alg/Qpa2.5/insulin 52.7 [59.3] 51.5 [54.0] 
 
Insulin control showed a reversal of charge around its isoelectric point as expected. 
The zeta potential of formulated complexes was consistently positive. The degree 
of positive charge appeared to be greater when complexes were formulated at a 
lower pH. This was expected as amine groups of pa2.5 would be more highly 
protonated at pH 4.6 than at 8.0, alg/Qpa2.5/insulin was less subject to change, 
probably due to the presence of quaternary ammonium groups. 
As discussed in chapter 3, zeta potential measuring ≥30 is indicative of colloidal 
stability, it would therefore appear that synthesised PECs were relatively stable. 
Furthermore, the positive potential value measured for insulin based PECs at pH 8 
was found to be less than the values measured for insulin free PEC controls 
discussed in chapter 3 (section 3.4.3 table 3.7), showing a degree of charge 
neutralisation possibly due to electrostatic interaction between insulin and PE+. 
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However, an unexpected reduction in Zeta potential was found for insulin 
complexes prepared at pH 4.6 compared to insulin free PEC controls. At pH 4.6, 
insulin should be positively charged and no additional charge neutralisations would 
be expected. This may indicate that alg/PE+/insulin might have been accompanied 
by the formation of alg/PE+ and alg/insulin complexes as well, leading to a wider 
distribution of charges and subsequently less definitive results, although there was 
no clear sign of extra peaks or widening charge distribution on examining zeta 
potential graphs. 
4.4.4 Transmission electron microscopy 
Figure 4.3 shows the results of TEM imaging for alg/pa2.5/insulin. 
 
Figure 4.3 TEM images for alg/pa2.5/insulin (A) 340000x (Bar= 20nm) (B) 
64000x (Bar =100nm). 
It appeared that alg/pa2.5/insulin resulted in small spherical particles less than 
10nm in diameter (Figure 4.3-A), and low resolution aggregates that may be 
accumulated insulin molecules, the arrows in figure 4.3-B indicate the small 
spherical particles. 





Figure 4.4 TEM images for alg/Qpa2.5/insulin (A) 450000x (Bar= 20 nm) (B) 
64000x (Bar= 100 nm). 
The results for alg/Qpa2.5/insulin were quite similar to those of alg/pa2.5/insulin, 
with the appearance of small spherical particles and larger aggregates. As seen in 
chapter 3 (section 3.4.6), size data from TEM appeared to show smaller particle 
sizes compared to DLS, which may be due to dehydration of the sample. 
The TEM results shown in chapter 3 (section 3.4.6) were based on PECs formed at 
a pH from 4.6-4.9, whereas those shown in figures 3 and 4 were prepared at pH 
8, it would therefore be difficult to compare between the two sets of images with 
regard to the disappearance of some of the objects seen in chapter 3, such as rod 
and needle shaped particles, as well as the large ‘particle trapping’ aggregates. 
4.4.5 Thermal analysis 
The thermal analysis of insulin and insulin PECs was performed in order to examine 
the effect of insulin on the thermal properties of the formulations. The thermal 
properties may also indicate whether an interaction between the polymers and 
insulin had taken place. 





Figure 4.5 DSC thermograms for insulin, alg/pa2.5 and alg/pa2.5/insulin. 
Using differential scanning calorimetry and thermogravimetric analysis, Surmacz-
Chwedoruk et al. found that insulin appeared to undergo thermal degradation at 
269°C with an onset temperature of 208°C (3). 
The thermogram for insulin in figure 4.5 shows an endotherm at 208°C, the cause 
of which is unclear. The exothermic peak at 248°C appears to be indicative of 
thermal decomposition, especially when viewed in combination with hot-stage 















































Figure 4.6 Hot stage images of insulin control at magnification x20. (A) Room 
temperature (B) 100°C (C) 260°C (D) 300°C (E) Cooled to room temperature. 
Discolouration of the insulin sample began at 240°C. Insulin is known to denature 
at temperatures approaching 70°C (4). The degradation assumed to have taken 
place in figure 4.6 was expected to be degradation at a more fundamental level. 
The assumption is based on to the observed contraction and discolouration of the 
sample seen in Figure 4.6, as well as its inability to return to its original state upon 
cooling. Early signs of discolouration were subtle; the white arrows in panels B and 
C may help in perceiving the start of discolouration that was more clearly evident 
in panels D and E.   
The complex of alg/pa2.5/insulin did not show any clear thermal events when 
examined by DSC, indicating a possible change in the thermal properties of insulin 
towards increased thermal stability, which may have been due to interaction with 
the polymers. 
However, Schmidt et al. found that the thermal stability of soy bean protein was 
decreased rather than increased in the presence of sodium dodecyl sulphate; this 
was attributed to changes in protein structure due to electrostatic and hydrophobic 
interactions (5). 




Figure 4.7 Hot stage images of alg/pa2.5/insulin at magnification x20. (A) Room 
temperature (B) 100°C (C) 190°C (D) 300°C (E) cooled to room temperature. 
Lyophilised preparations of alg/pa2.5/insulin began to contract and become 
irreversibly discoloured at 170°C, which is similar to the hot stage results of 
alg/pa2.5 1:3 (Section 3.4.5), albeit with a slightly earlier onset of discolouration.  




Figure 4.8 DSC thermograms of insulin, alg/Qpa2.5 and alg/Qpa2.5/Insulin. 
In a result similar to non-quaternised complexes, alg/Qpa2.5/Insulin did not 
exhibit any detectable thermal events over the temperature range measured. 
It would seem that when used as part of a PEC, the structure of insulin is affected 
in a way that leads to changes in its thermal properties. 















































Figure 4.9 Hot stage images of alg/Qpa2.5/insulin at magnification x20. (A) Room 
temperature (B) 100°C (C) 250°C (D) 300°C (E) Cooled to room temperature. 
Figure 4.9 appeared to show sample discolouration beginning at approximately 
220°C, while sample contraction began at 280°C. This result was slightly greater 
than temperatures seen with alg/Qpa2.5 1:3 alone (200°C).  
Again it would seem that the only change with the addition of insulin was the 
appearance of sample contraction and slight changes in temperature of onset of 
sample discolouration. Sarmento et al. found that the apparent decomposition 
temperature of unloaded alginate/chitosan nanoparticle was different from that of 
equivalent insulin-loaded nanoparticles (6). The changes in apparent 
decomposition temperatures were different between non-quaternised (earlier 
onset of discolouration) and quaternised insulin PECs (later onset of 
discolouration), suggesting a difference in the interaction with insulin of the two 
types of PECs. 
4.4.6 Infra-red analysis. 
Lyophilised samples of PECs and insulin control were investigated by IR analysis 
in order to help understand whether an electrostatic interaction had taken place 
between the PE components. 
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Figure 4.10 shows the results of IR analysis for insulin control, and alg/pa2.5 based 
PECs.  
 
Figure 4.10 IR spectra of insulin alone, alg/pa2.5 PEC, and alg/pa2.5/insulin PEC. 
Insulin exhibits amide stretching bands at 1649cm-1 and 1538cm-1, a common 
feature in IR spectra of peptides and proteins (7). 
The spectrum of alg/pa2.5/Insulin combines aspects of all three components, 
alginate is represented by C-O-C stretching bands at 1031-1082cm-1, pa2.5 
exhibited C-H stretching vibrations at 2920cm-1 and 2852cm-1, while Insulin 
provided the amide bands at 1644cm-1 and 1538cm-1. 
The small shift in the amide bands of insulin may indicate some type of interaction 
with one or both of the components of the PEC. Patil and Devarajan used IR to 
indicate the association of insulin with alginic acid nanoparticles by the appearance 
of amide bands associated with peptides (8). While Sarmento et al. used the same 
technique albeit using chitosan/alginate/insulin nanoparticles, showing a small 
shift in the vibrational frequency of an amide band compared to insulin spectrum 
(6). Both groups attributed small changes in the vibrational frequencies of ionic 







































































































































































































Figure 4.11 shows the results of IR analysis for alg/Qpa2.5 based complexes and 
insulin. 
 
Figure 4.11 IR spectra of insulin alone, alg/Qpa2.5 PEC, and alg/Qpa2.5/Insulin 
PEC. 
The IR spectrum of alg/Qpa2.5/Insulin appeared to show similar results to its non-
quaternised equivalent, whereby the amide stretching of insulin appeared to have 
shifted to 1644cm-1 and 1541cm-1. Furthermore, there appeared to be a degree of 
overlap, leading to the widening of the signal at 1644cm-1 compared to 1649cm-1 
in the insulin spectrum. 
4.4.7 Determination of insulin complexation 
Figure 4.12 shows the calibration curve prepared from insulin standard solutions 


































































































































































































Figure 4.12 Calibration curve of insulin standard solutions (±SD, n=3). 
The coefficient of determination (R2) was found to be 0.9999 while the limit of 
detection was 0.012mg/mL and limit of quantification was 0.036mg/mL. 
Estimations of insulin complexation efficiency can be seen in table 4.2. 
Table 4.2 Average estimated complexation efficiency of alg/pa2.5/insulin and 
alg/Qpa2.5/insulin, (n=3 ± SD). 
Sample Average complexation efficiency, % 
alg/pa2.5/insulin 96.1 (±7.7) 
alg/Qpa2.5/insulin 91.4 (±6.1) 
 
Figure 4.13 show the HPLC chromatographs of alg/PE+/insulin PECs and insulin 
control. 
 








































Figure 4.13 HPLC chromatographs with retention times in minutes. (A) Insulin 
control (B) alg/pa2.5/Insulin (C) alg/Qpa2.5/Insulin. 
Results showed that the preparation processes, and assumed complexation 
appeared to have little to no effect on insulin retention time, with a single peak 
representing the insulin molecule the only peak detected in all cases. The retention 
time and area under the curve remained relatively unaffected even after 48 hours.  
4.4.8 α-Chymotrypsin enzyme study 







Figure 4.14 Results of α-chymotrypsin enzymatic degradation studies for insulin 
based PECs.  Insulin control  alg/Qpa2.5/insulin  alg/pa2.5/insulin (Mean ± 
SD, n=3, * Results at 1 hour mark were based on 2 rather than three data points. 
From figure 4.14 it can be seen that approximately 65% of the insulin control 
sample was degraded within the first 15 minutes. This is similar to the result found 
by Zhang et al. while studying the stability of insulin in the presence of intestinal 
proteases (9). 
The results showed that complexation with insulin led to an increase in the 
degradation of insulin incorporated into PECs compared to free insulin control. The 
reason for this is not known, however it may be the case that the structure of the 
insulin is altered or uncoiled due to electrostatic interaction and target sites of 
alpha-chymotrypsin are exposed to the enzyme, leading to the rapid degradation 
seen over 15 minutes where less than 5% of insulin remained intact. Thompson et 
al. found a similar result when using PECs of insulin and amphiphilic poly (allyl 
amine), although their PEC resulted in a smaller increase in insulin degradation in 
comparison to the findings of this experiment (1). 
This may indicate that not only did alginate fail to provide enzyme inhibition by 
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sensitivity to α-chymotrypsin. In comparison, the use of poly (acrylates), 
polycarbophil and carbomer have been shown to inhibit the activity of α-
chymotrypsin in an experiment using solution of poly (acrylates) and N-acetyl-L-
tyrosine as enzyme substrate by chelating Ca+2 ions which acts as a co-factor in 
α-chymotrypsin activity (10). 
Other PE’s have resulted in enhanced enzyme activity, with enzymes such as 
trypsin and carboxypeptidase B having been shown by Lueßen et al. to have their 
degradative effects increased in the presence of a chitosan solution in a model 
using enzyme substrates, no explanation was given as to the cause (11).  Kotze 
et al found that chitosan was not able to protect insulin or buserelin from the 
enzymatic action of α-chymotrypsin (12). 
Despite this result, it was clear that one or both components of the PECs interact 
with insulin in some way. It may simply be the case of finding the PE, or optimum 
ratio of PEs, that interact in a manner that leads to the protection rather than the 















4.5 Conclusion   
The results of DLS appeared to show that the Hdd and pdI of resultant PECs was 
affected by the addition of insulin, the details of this interaction were unclear, but 
may have been due to a difference in the way insulin interacts with pa2.5 and 
Qpa2.5. The role of alginate as a competing anionic PE did not appear to be 
detrimental to PEC formation.  
The %Transmittance of light for PECs was less than that for insulin free PECs, 
regardless of DLS results, although there were no signs of reduced stability over 
48 hours. 
Zeta potential, as discussed earlier can be used as a measure of stability in colloidal 
preparations, and appeared to indicate the formation of stable nano-sized colloidal 
aggregates. 
The results of thermal analysis showed that the addition of insulin to PECs 
appeared to have led to changes in the thermal properties of PEs, which may have 
been due to changes in interactions and subsequent changes to final PEC structure. 
Infra-red analysis, which has been used in the literature to show electrostatic 
interaction between PEs, appeared to show changes in the vibrational frequencies 
of charge bearing groups of PEC components, indicating what was presumed to be 
electrostatic interaction. 
Enzymatic degradation studies showed that the prepared PECs were not able to 
protect insulin from the degradative effects of α-chymotrypsin. Indeed results 
would show that the interaction between insulin and the polymers used led to more 
rapid enzymatic cleavage of insulin compared to the peptide alone. 
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5. General conclusion 
This work showed that amphiphilic poly (allyl amine) and its quaternised derivative 
were able to form a stable PEC with sodium alginate at investigated mass ratios. 
Using a simple mixing procedure, solutions of PEs were combined and analysed in 
the liquid and solid state (following lyophilisation), with results indicating the 
formation of nano-sized spherical, rod shaped, and aggregated spherical particles. 
Furthermore, the combination appeared to lead to changes in the physicochemical 
properties of PEs, such as changes in apparent decomposition temperature. Infra-
red analysis was used to show that the electrostatic interaction between charge 
carrying groups on PEs might be related to shifts in vibrational frequencies of said 
groups.   
The incorporation of insulin into a PEC with alginate and the amphiphilic polymers 
was undertaken with a view to studying the practicality of these complexes in the 
enzymatic protection of insulin. Results of DLS analysis suggested the formation 
of nano-sized aggregates in the range of 150-250nm, while TEM images appeared 
to show spherical nanoparticles with much smaller dimensions (less than 10nm). 
The incorporation of insulin into PECs appeared to further alter their thermal 
properties, leading to additional changes in what was assumed to be the 
decomposition temperature. As with alg/PE+ complexes, changes in IR spectra of 
alg/PE+/insulin complexes were assumed to represent electrostatic interaction 
between the charged groups of the polymers and insulin. Based on HPLC studies, 
the process of integrating insulin with the alg/PE+ complex was shown to have little 
to no effect on the insulin molecule, which showed no change in the retention time 
of the insulin molecule. Furthermore the complexation efficiency of the complexes 
was found to be greater than 90%.  
Finally, the effect of using insulin as part of a PEC with alginate and amphiphilic 
polymers, in the protection of the insulin molecule from the enzymatic cleavage of 
α-chymotrypsin was investigated using HPLC. It was found that insulin PECs were 
not able to protect the peptide from the degradative effects of the enzyme. On the 
contrary, the incorporation of insulin in the PEC led to acceleration in the 





6. Future work 
Following on from this work, it would appear that some alterations may be required 
in order to achieve improved enzymatic protection of insulin. Such future works 
may include the reduction in level of palmitoylation, while increasing the level of 
quaternisation. Moreover, the use hydrophobic grafts other than palmitic acid 
could be investigated.  
The use of amphiphilic polymers in combination with an anionic polymer of known 
enzyme inhibiting characteristics might result in more favourable outcomes. 
Another possibility is the palmitoylation of the insulin molecule itself rather than 
just the polymers with a view to enhancing hydrophobic interaction of the peptide 
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